<?xml version="1.0" encoding="UTF-8"?><!-- Normalized for easier text mining. --><xocs:doc xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.elsevier.com/xml/ja/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://schema.elsevier.com/dtds/document/fulltext/xcr/xocs-article.xsd"><xocs:meta><xocs:content-family>serial</xocs:content-family><xocs:content-type>JL</xocs:content-type><xocs:cid>286331</xocs:cid><xocs:srctitle>Stem Cell Reports</xocs:srctitle><xocs:normalized-srctitle>STEMCELLREPORTS</xocs:normalized-srctitle><xocs:orig-load-date>2014-01-02</xocs:orig-load-date><xocs:ew-transaction-id>2014-01-15T12:46:19</xocs:ew-transaction-id><xocs:eid>1-s2.0-S2213671113001306</xocs:eid><xocs:pii-formatted>S2213-6711(13)00130-6</xocs:pii-formatted><xocs:pii-unformatted>S2213671113001306</xocs:pii-unformatted><xocs:doi>10.1016/j.stemcr.2013.11.005</xocs:doi><xocs:item-stage>S300</xocs:item-stage><xocs:item-version-number>S300.2</xocs:item-version-number><xocs:item-weight>FULL-TEXT</xocs:item-weight><xocs:hub-eid>1-s2.0-S2213671114X00020</xocs:hub-eid><xocs:timestamp>2014-02-03T15:49:17.288084-05:00</xocs:timestamp><xocs:issns><xocs:issn-primary-formatted>2213-6711</xocs:issn-primary-formatted><xocs:issn-primary-unformatted>22136711</xocs:issn-primary-unformatted></xocs:issns><xocs:sponsored-access-type>UNLIMITED</xocs:sponsored-access-type><xocs:funding-body-id>NIH</xocs:funding-body-id><xocs:crossmark>true</xocs:crossmark><xocs:vol-first>2</xocs:vol-first><xocs:iss-first>1</xocs:iss-first><xocs:vol-iss-suppl-text>Volume 2, Issue 1</xocs:vol-iss-suppl-text><xocs:sort-order>8</xocs:sort-order><xocs:first-fp>64</xocs:first-fp><xocs:last-lp>77</xocs:last-lp><xocs:pages><xocs:first-page>64</xocs:first-page><xocs:last-page>77</xocs:last-page></xocs:pages><xocs:cover-date-orig><xocs:start-date>20140114</xocs:start-date></xocs:cover-date-orig><xocs:cover-date-text>14 January 2014</xocs:cover-date-text><xocs:cover-date-start>2014-01-14</xocs:cover-date-start><xocs:cover-date-year>2014</xocs:cover-date-year><xocs:hub-sec><xocs:hub-sec-title>Articles</xocs:hub-sec-title></xocs:hub-sec><xocs:document-type>article</xocs:document-type><xocs:document-subtype>fla</xocs:document-subtype><xocs:copyright-line>Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.</xocs:copyright-line><xocs:normalized-article-title>HUMANRPESTEMCELLSGROWNPOLARIZEDRPEMONOLAYERSAPOLYESTERMATRIXMAINTAINEDAFTERGRAFTINGRABBITSUBRETINALSPACE</xocs:normalized-article-title><xocs:normalized-first-auth-surname>STANZEL</xocs:normalized-first-auth-surname><xocs:normalized-first-auth-initial>B</xocs:normalized-first-auth-initial><xocs:item-toc><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Results</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Preparation and Characterization of the RPE-Carrier Monolayers</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Cultured hRPE Xenografted into Rabbit SRS</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Characterization of hRPE Xenografts by Immunolabeling and Transmission Electron Microscopy</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Effect of Systemic Immunosuppression on Fetal RPE Transplant and Retinal Integrity</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Discussion</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Experimental Procedures</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>RPE Cultures</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Fetal RPE</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Adult RPE</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Transepithelial Electrical Resistance Measurements</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Quantitative PCR</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Preparation of Implants</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Rabbit Transplantation</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Immunosuppression</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Local</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Systemic</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>In Vivo Follow-Up</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Spectral Domain Optical Coherence Tomography and Confocal Scanning Laser Ophthalmoscopy</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Color Fundus Photographs</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Histology</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Perfusion Fixation and Sectioning</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Transmission Electron Microscopy</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Immunolabeling</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Transwell Membranes</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Paraffin Sections</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:acknowledgment"><xocs:item-toc-section-title>Acknowledgments</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:appendices"><xocs:item-toc-section-title>Supplemental Information</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:bibliography"><xocs:item-toc-section-title>References</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc><xocs:references><xocs:ref-info refid="sref1"><xocs:ref-normalized-surname>ABE</xocs:ref-normalized-surname><xocs:ref-pub-year>1999</xocs:ref-pub-year><xocs:ref-first-fp>179</xocs:ref-first-fp><xocs:ref-last-lp>189</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref2"><xocs:ref-normalized-surname>BHATT</xocs:ref-normalized-surname><xocs:ref-pub-year>1994</xocs:ref-pub-year><xocs:ref-first-fp>214</xocs:ref-first-fp><xocs:ref-last-lp>221</xocs:ref-last-lp><xocs:ref-normalized-initial>N</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref3"><xocs:ref-normalized-surname>BINDER</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>516</xocs:ref-first-fp><xocs:ref-last-lp>554</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref4"><xocs:ref-normalized-surname>BLENKINSOP</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>45</xocs:ref-first-fp><xocs:ref-last-lp>65</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref5"><xocs:ref-normalized-surname>BONILHA</xocs:ref-normalized-surname><xocs:ref-pub-year>1999</xocs:ref-pub-year><xocs:ref-first-fp>1533</xocs:ref-first-fp><xocs:ref-last-lp>1548</xocs:ref-last-lp><xocs:ref-normalized-initial>V</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref6"><xocs:ref-normalized-surname>BUNTMILAM</xocs:ref-normalized-surname><xocs:ref-pub-year>1983</xocs:ref-pub-year><xocs:ref-first-fp>703</xocs:ref-first-fp><xocs:ref-last-lp>712</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref7"><xocs:ref-normalized-surname>BURKE</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>579</xocs:ref-first-fp><xocs:ref-last-lp>595</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref8"><xocs:ref-normalized-surname>CARR</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>e8152</xocs:ref-first-fp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref9"><xocs:ref-normalized-surname>DACRUZ</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>598</xocs:ref-first-fp><xocs:ref-last-lp>635</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref10"><xocs:ref-normalized-surname>DELPRIORE</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>472</xocs:ref-first-fp><xocs:ref-last-lp>480</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref11"><xocs:ref-normalized-surname>DINIZ</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>5087</xocs:ref-first-fp><xocs:ref-last-lp>5096</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref12"><xocs:ref-normalized-surname>ENZMANN</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>530</xocs:ref-first-fp><xocs:ref-last-lp>534</xocs:ref-last-lp><xocs:ref-normalized-initial>V</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref13"><xocs:ref-normalized-surname>GABRIELIAN</xocs:ref-normalized-surname><xocs:ref-pub-year>1999</xocs:ref-pub-year><xocs:ref-first-fp>326</xocs:ref-first-fp><xocs:ref-last-lp>335</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref14"><xocs:ref-normalized-surname>HE</xocs:ref-normalized-surname><xocs:ref-pub-year>1994</xocs:ref-pub-year><xocs:ref-first-fp>257</xocs:ref-first-fp><xocs:ref-last-lp>261</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref15"><xocs:ref-normalized-surname>HIRAMI</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>126</xocs:ref-first-fp><xocs:ref-last-lp>131</xocs:ref-last-lp><xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref16"><xocs:ref-normalized-surname>HU</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>14</xocs:ref-first-fp><xocs:ref-last-lp>19</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref17"><xocs:ref-normalized-surname>HUANG</xocs:ref-normalized-surname><xocs:ref-pub-year>1998</xocs:ref-pub-year><xocs:ref-first-fp>573</xocs:ref-first-fp><xocs:ref-last-lp>585</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref18"><xocs:ref-normalized-surname>HYNES</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>763</xocs:ref-first-fp><xocs:ref-last-lp>778</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref19"><xocs:ref-normalized-surname>IVERT</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>232</xocs:ref-first-fp><xocs:ref-last-lp>237</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref20"><xocs:ref-normalized-surname>JEKLOVA</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>231</xocs:ref-first-fp><xocs:ref-last-lp>240</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref21"><xocs:ref-normalized-surname>JIANG</xocs:ref-normalized-surname><xocs:ref-pub-year>1994</xocs:ref-pub-year><xocs:ref-first-fp>719</xocs:ref-first-fp><xocs:ref-last-lp>728</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref22"><xocs:ref-normalized-surname>KEARNS</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>2013</xocs:ref-first-fp><xocs:ref-last-lp>2021</xocs:ref-last-lp><xocs:ref-normalized-initial>V</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref23"><xocs:ref-normalized-surname>KLIMANSKAYA</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>217</xocs:ref-first-fp><xocs:ref-last-lp>245</xocs:ref-last-lp><xocs:ref-normalized-initial>I</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref24"><xocs:ref-normalized-surname>LAI</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>3442</xocs:ref-first-fp><xocs:ref-last-lp>3456</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref25"><xocs:ref-normalized-surname>LAI</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>3134</xocs:ref-first-fp><xocs:ref-last-lp>3141</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref26"><xocs:ref-normalized-surname>LIAO</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>4229</xocs:ref-first-fp><xocs:ref-last-lp>4238</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref27"><xocs:ref-normalized-surname>LIM</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>1728</xocs:ref-first-fp><xocs:ref-last-lp>1738</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref28"><xocs:ref-normalized-surname>LIU</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>1386</xocs:ref-first-fp><xocs:ref-normalized-initial>Z</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref29"><xocs:ref-normalized-surname>LU</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>659</xocs:ref-first-fp><xocs:ref-last-lp>667</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref30"><xocs:ref-normalized-surname>MONTEZUMA</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>3514</xocs:ref-first-fp><xocs:ref-last-lp>3522</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref31"><xocs:ref-normalized-surname>NICOLINI</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>527</xocs:ref-first-fp><xocs:ref-last-lp>531</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref32"><xocs:ref-normalized-surname>PENG</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>1392</xocs:ref-first-fp><xocs:ref-last-lp>1403</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref33"><xocs:ref-normalized-surname>PHILP</xocs:ref-normalized-surname><xocs:ref-pub-year>1998</xocs:ref-pub-year><xocs:ref-first-fp>R1824</xocs:ref-first-fp><xocs:ref-last-lp>R1828</xocs:ref-last-lp><xocs:ref-normalized-initial>N</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref34"><xocs:ref-normalized-surname>REDMOND</xocs:ref-normalized-surname><xocs:ref-pub-year>1998</xocs:ref-pub-year><xocs:ref-first-fp>344</xocs:ref-first-fp><xocs:ref-last-lp>351</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref35"><xocs:ref-normalized-surname>REZAI</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>352</xocs:ref-first-fp><xocs:ref-last-lp>358</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref36"><xocs:ref-normalized-surname>SALERO</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>88</xocs:ref-first-fp><xocs:ref-last-lp>95</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref37"><xocs:ref-normalized-surname>SCHWARTZ</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>713</xocs:ref-first-fp><xocs:ref-last-lp>720</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref38"><xocs:ref-normalized-surname>SHENG</xocs:ref-normalized-surname><xocs:ref-pub-year>1995</xocs:ref-pub-year><xocs:ref-first-fp>381</xocs:ref-first-fp><xocs:ref-last-lp>390</xocs:ref-last-lp><xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref39"><xocs:ref-normalized-surname>SINGER</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>1175</xocs:ref-first-fp><xocs:ref-last-lp>1183</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref40"><xocs:ref-normalized-surname>SINGH</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>6767</xocs:ref-first-fp><xocs:ref-last-lp>6778</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref41"><xocs:ref-normalized-surname>STANZEL</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial><xocs:ref-normalized-srctitle>OPHTHALMICSURGERYPRINCIPLESPRACTICE</xocs:ref-normalized-srctitle><xocs:ref-normalized-article-title>SURGICALSTRATEGIESFORAMD</xocs:ref-normalized-article-title></xocs:ref-info><xocs:ref-info refid="sref42"><xocs:ref-normalized-surname>STANZEL</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>490</xocs:ref-first-fp><xocs:ref-last-lp>500</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref43"><xocs:ref-normalized-surname>STRAUSS</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>845</xocs:ref-first-fp><xocs:ref-last-lp>881</xocs:ref-last-lp><xocs:ref-normalized-initial>O</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref44"><xocs:ref-normalized-surname>SUBRIZI</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>8047</xocs:ref-first-fp><xocs:ref-last-lp>8054</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref45"><xocs:ref-normalized-surname>SUGINO</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>4979</xocs:ref-first-fp><xocs:ref-last-lp>4997</xocs:ref-last-lp><xocs:ref-normalized-initial>I</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref46"><xocs:ref-normalized-surname>SUGITA</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>263</xocs:ref-first-fp><xocs:ref-last-lp>268</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref47"><xocs:ref-normalized-surname>SZURMAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>4983</xocs:ref-first-fp><xocs:ref-last-lp>4989</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref48"><xocs:ref-normalized-surname>VANZEEBURG</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>120</xocs:ref-first-fp><xocs:ref-last-lp>127</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref49"><xocs:ref-normalized-surname>VERSTRAETEN</xocs:ref-normalized-surname><xocs:ref-pub-year>1993</xocs:ref-pub-year><xocs:ref-first-fp>849</xocs:ref-first-fp><xocs:ref-last-lp>854</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref50"><xocs:ref-normalized-surname>WANG</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>643</xocs:ref-first-fp><xocs:ref-last-lp>649</xocs:ref-last-lp><xocs:ref-normalized-initial>F</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref51"><xocs:ref-normalized-surname>WENKEL</xocs:ref-normalized-surname><xocs:ref-pub-year>1998</xocs:ref-pub-year><xocs:ref-first-fp>1823</xocs:ref-first-fp><xocs:ref-last-lp>1834</xocs:ref-last-lp><xocs:ref-normalized-initial>H</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref52"><xocs:ref-normalized-surname>WENKEL</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>3467</xocs:ref-first-fp><xocs:ref-last-lp>3473</xocs:ref-last-lp><xocs:ref-normalized-initial>H</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref53"><xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname><xocs:ref-pub-year>1998</xocs:ref-pub-year><xocs:ref-first-fp>1021</xocs:ref-first-fp><xocs:ref-last-lp>1027</xocs:ref-last-lp><xocs:ref-normalized-initial>X</xocs:ref-normalized-initial></xocs:ref-info></xocs:references><xocs:attachment-metadata-doc><xocs:attachment-set-type>item</xocs:attachment-set-type><xocs:pii-formatted>S2213-6711(13)00130-6</xocs:pii-formatted><xocs:pii-unformatted>S2213671113001306</xocs:pii-unformatted><xocs:eid>1-s2.0-S2213671113001306</xocs:eid><xocs:doi>10.1016/j.stemcr.2013.11.005</xocs:doi><xocs:cid>286331</xocs:cid><xocs:timestamp>2014-01-15T13:25:31.778802-05:00</xocs:timestamp><xocs:path>/286331/1-s2.0-S2213671114X00020/1-s2.0-S2213671113001306/</xocs:path><xocs:cover-date-start>2014-01-14</xocs:cover-date-start><xocs:sponsored-access-type>UNLIMITED</xocs:sponsored-access-type><xocs:funding-body-id>NIH</xocs:funding-body-id><xocs:attachments><xocs:web-pdf><xocs:attachment-eid>1-s2.0-S2213671113001306-main.pdf</xocs:attachment-eid><xocs:filename>main.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:pdf-optimized>true</xocs:pdf-optimized><xocs:filesize>4239801</xocs:filesize><xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose><xocs:web-pdf-page-count>14</xocs:web-pdf-page-count><xocs:web-pdf-images><xocs:web-pdf-image><xocs:attachment-eid>1-s2.0-S2213671113001306-main_1.png</xocs:attachment-eid><xocs:filename>main_1.png</xocs:filename><xocs:extension>png</xocs:extension><xocs:filesize>129841</xocs:filesize><xocs:pixel-height>849</xocs:pixel-height><xocs:pixel-width>656</xocs:pixel-width><xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type><xocs:pdf-page-num>1</xocs:pdf-page-num></xocs:web-pdf-image></xocs:web-pdf-images></xocs:web-pdf><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc2.sml</xocs:attachment-eid><xocs:file-basename>mmc2</xocs:file-basename><xocs:filename>mmc2.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>15778</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-MMC-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc4.sml</xocs:attachment-eid><xocs:file-basename>mmc4</xocs:file-basename><xocs:filename>mmc4.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>10812</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-MMC-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc6.sml</xocs:attachment-eid><xocs:file-basename>mmc6</xocs:file-basename><xocs:filename>mmc6.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>11589</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-MMC-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc3.sml</xocs:attachment-eid><xocs:file-basename>mmc3</xocs:file-basename><xocs:filename>mmc3.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>9640</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-MMC-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc5.sml</xocs:attachment-eid><xocs:file-basename>mmc5</xocs:file-basename><xocs:filename>mmc5.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>10721</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-MMC-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc4.mp4</xocs:attachment-eid><xocs:file-basename>mmc4</xocs:file-basename><xocs:filename>mmc4.mp4</xocs:filename><xocs:extension>mp4</xocs:extension><xocs:filesize>2913833</xocs:filesize><xocs:attachment-type>VIDEO</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc6.mp4</xocs:attachment-eid><xocs:file-basename>mmc6</xocs:file-basename><xocs:filename>mmc6.mp4</xocs:filename><xocs:extension>mp4</xocs:extension><xocs:filesize>2926532</xocs:filesize><xocs:attachment-type>VIDEO</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc5.mp4</xocs:attachment-eid><xocs:file-basename>mmc5</xocs:file-basename><xocs:filename>mmc5.mp4</xocs:filename><xocs:extension>mp4</xocs:extension><xocs:filesize>2934658</xocs:filesize><xocs:attachment-type>VIDEO</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc3.mp4</xocs:attachment-eid><xocs:file-basename>mmc3</xocs:file-basename><xocs:filename>mmc3.mp4</xocs:filename><xocs:extension>mp4</xocs:extension><xocs:filesize>2216529</xocs:filesize><xocs:attachment-type>VIDEO</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc2.mp4</xocs:attachment-eid><xocs:file-basename>mmc2</xocs:file-basename><xocs:filename>mmc2.mp4</xocs:filename><xocs:extension>mp4</xocs:extension><xocs:filesize>14819948</xocs:filesize><xocs:attachment-type>VIDEO</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc4.flv</xocs:attachment-eid><xocs:file-basename>mmc4</xocs:file-basename><xocs:filename>mmc4.flv</xocs:filename><xocs:extension>flv</xocs:extension><xocs:filesize>2157091</xocs:filesize><xocs:pixel-height>720</xocs:pixel-height><xocs:pixel-width>960</xocs:pixel-width><xocs:attachment-type>VIDEO-FLASH</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc6.flv</xocs:attachment-eid><xocs:file-basename>mmc6</xocs:file-basename><xocs:filename>mmc6.flv</xocs:filename><xocs:extension>flv</xocs:extension><xocs:filesize>2135827</xocs:filesize><xocs:pixel-height>720</xocs:pixel-height><xocs:pixel-width>960</xocs:pixel-width><xocs:attachment-type>VIDEO-FLASH</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc5.flv</xocs:attachment-eid><xocs:file-basename>mmc5</xocs:file-basename><xocs:filename>mmc5.flv</xocs:filename><xocs:extension>flv</xocs:extension><xocs:filesize>2154782</xocs:filesize><xocs:pixel-height>720</xocs:pixel-height><xocs:pixel-width>960</xocs:pixel-width><xocs:attachment-type>VIDEO-FLASH</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc3.flv</xocs:attachment-eid><xocs:file-basename>mmc3</xocs:file-basename><xocs:filename>mmc3.flv</xocs:filename><xocs:extension>flv</xocs:extension><xocs:filesize>1687627</xocs:filesize><xocs:pixel-height>720</xocs:pixel-height><xocs:pixel-width>960</xocs:pixel-width><xocs:attachment-type>VIDEO-FLASH</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc2.flv</xocs:attachment-eid><xocs:file-basename>mmc2</xocs:file-basename><xocs:filename>mmc2.flv</xocs:filename><xocs:extension>flv</xocs:extension><xocs:filesize>9492153</xocs:filesize><xocs:pixel-height>480</xocs:pixel-height><xocs:pixel-width>640</xocs:pixel-width><xocs:attachment-type>VIDEO-FLASH</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-gr3.jpg</xocs:attachment-eid><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>181628</xocs:filesize><xocs:pixel-height>975</xocs:pixel-height><xocs:pixel-width>629</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-gr4.jpg</xocs:attachment-eid><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>115306</xocs:filesize><xocs:pixel-height>385</xocs:pixel-height><xocs:pixel-width>769</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-fx1.jpg</xocs:attachment-eid><xocs:file-basename>fx1</xocs:file-basename><xocs:abstract-attachment>true</xocs:abstract-attachment><xocs:filename>fx1.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>42253</xocs:filesize><xocs:pixel-height>375</xocs:pixel-height><xocs:pixel-width>358</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-gr2.jpg</xocs:attachment-eid><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>90229</xocs:filesize><xocs:pixel-height>398</xocs:pixel-height><xocs:pixel-width>768</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-gr1.jpg</xocs:attachment-eid><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>244563</xocs:filesize><xocs:pixel-height>776</xocs:pixel-height><xocs:pixel-width>769</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-gr3.sml</xocs:attachment-eid><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>8675</xocs:filesize><xocs:pixel-height>163</xocs:pixel-height><xocs:pixel-width>105</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-gr4.sml</xocs:attachment-eid><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>12806</xocs:filesize><xocs:pixel-height>110</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-fx1.sml</xocs:attachment-eid><xocs:file-basename>fx1</xocs:file-basename><xocs:abstract-attachment>true</xocs:abstract-attachment><xocs:filename>fx1.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>6950</xocs:filesize><xocs:pixel-height>163</xocs:pixel-height><xocs:pixel-width>156</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-gr2.sml</xocs:attachment-eid><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>12152</xocs:filesize><xocs:pixel-height>113</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-gr1.sml</xocs:attachment-eid><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>13613</xocs:filesize><xocs:pixel-height>163</xocs:pixel-height><xocs:pixel-width>162</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113001306-mmc1.pdf</xocs:attachment-eid><xocs:file-basename>mmc1</xocs:file-basename><xocs:filename>mmc1.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:filesize>832374</xocs:filesize><xocs:attachment-type>APPLICATION</xocs:attachment-type></xocs:attachment></xocs:attachments></xocs:attachment-metadata-doc><xocs:refkeys><xocs:refkey3>STANZELX2014X64</xocs:refkey3><xocs:refkey4lp>STANZELX2014X64X77</xocs:refkey4lp><xocs:refkey4ai>STANZELX2014X64XB</xocs:refkey4ai><xocs:refkey5>STANZELX2014X64X77XB</xocs:refkey5></xocs:refkeys><xocs:open-access><xocs:oa-article-status is-open-access="1" is-open-archive="0">Full</xocs:oa-article-status><xocs:oa-access-effective-date>2013-11-11T19:08:35Z</xocs:oa-access-effective-date><xocs:oa-sponsor><xocs:oa-sponsor-type>ElsevierWaived</xocs:oa-sponsor-type></xocs:oa-sponsor><xocs:oa-user-license>http://creativecommons.org/licenses/by/3.0/</xocs:oa-user-license></xocs:open-access></xocs:meta><xocs:serial-item><article xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" docsubtype="fla" version="5.2" xml:lang="en"><item-info><jid>STEMCR</jid><aid>57</aid><ce:pii>S2213-6711(13)00130-6</ce:pii><ce:doi>10.1016/j.stemcr.2013.11.005</ce:doi><ce:copyright type="other" year="2014">The Authors</ce:copyright></item-info><ce:floats><ce:figure id="fig1"><ce:label>Figure 1</ce:label><ce:caption id="cap0015"><ce:simple-para id="fspara0010" view="all">Fetal and Adult Human RPE Cultured over 2 Months Exhibit Similarities to Native RPE</ce:simple-para><ce:simple-para id="fspara0015" view="all">(A and B) Cultured (A) fetal and (B) adult hRPE display hexagonal morphology and varied pigmentation. The scale bars represent 50 μm.</ce:simple-para><ce:simple-para id="fspara0020" view="all">(C and D) TER measurements of fetal and adult hRPE, respectively.</ce:simple-para><ce:simple-para id="fspara0025" view="all">(E) mRNA expression of typical RPE transcripts was compared to its genetically matched native RPE counterpart from five adult hRPE donors, including those used for transplantation. The asterisk denotes P value &gt; 0.01/paired t test. The error bars represent SEM.</ce:simple-para><ce:simple-para id="fspara0030" view="all">(F) Adult hRPE cultures display expression of markers typical of native RPE in their polarized localization. DAPI is cyan, whereas all other immunofluorescence is gold. Claudin 19, ezrin, ZO1, and MCT1 are preferentially located on the apical side. RPE65 and CRALBP are cytoplasmic. The scale bars represent 10 μm.</ce:simple-para><ce:simple-para id="fspara0035" view="all">See also <ce:cross-ref refid="app2" id="crosref0500">Figure S1</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr1"/></ce:figure><ce:figure id="fig2"><ce:label>Figure 2</ce:label><ce:caption id="cap0020"><ce:simple-para id="fspara0040" view="all">Representative Case of Fetal and hRPE Transplantation into Immune Competent-Rabbit SRS with In Vivo and Histomorphological Comparison</ce:simple-para><ce:simple-para id="fspara0045" view="all">(A and C) Funduscopy images of subretinal RPE + PET implant at respective time points, (A1-A3 and C1) infrared cSLO images, (C2 and C3) color fundus photograph, (A4 and C4) postmortem eye-cup macroscopic photograph. (B and D) Longitudinal section through center of RPE + PET implant center at indicated time points, (B1-B3 and D1-D3) SD-OCT images, and (B4 and D4) paraffin and resin histologic section, respectively. Scale bars in columns A-D and rows 1-3 are 200 μm and, in row 4, 250 μm.</ce:simple-para><ce:simple-para id="fspara0050" view="all">See also <ce:cross-ref refid="app2" id="crosref0505">Figure S2</ce:cross-ref> and <ce:cross-ref refid="app2" id="crosref0510">S3</ce:cross-ref> and <ce:cross-ref refid="mmc2" id="crosref0515">Movies S1</ce:cross-ref>, <ce:cross-ref refid="mmc3" id="crosref0520">S2</ce:cross-ref>, <ce:cross-ref refid="mmc4" id="crosref0525">S3</ce:cross-ref>, and <ce:cross-ref refid="mmc5" id="crosref0530">S4</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr2"/></ce:figure><ce:figure id="fig3"><ce:label>Figure 3</ce:label><ce:caption id="cap0025"><ce:simple-para id="fspara0055" view="all">Xenografted Polarized Human RPEs Survive Subretinally for at Least 1 Month</ce:simple-para><ce:simple-para id="fspara0060" view="all">One month after hRPE transplantation, implant sites were screened for human-specific and RPE markers.</ce:simple-para><ce:simple-para id="fspara0065" view="all">(A) Fetal hRPE stained for pan-cytokeratin (scale bar, 50 μm); inset shows section overview stained with hematoxylin/eosin (scale bar, 200 μm).</ce:simple-para><ce:simple-para id="fspara0070" view="all">(B) Fetal hRPE stained for SC121 (red) and MCT1 (green; scale bars, 125 μm and 25 μm [inset]).</ce:simple-para><ce:simple-para id="fspara0075" view="all">(C) Adult hRPE stained for pan-cytokeratin (scale bar = 50 μm); inset shows section overview stained with hematoxylin/eosin (scale bar, 200 μm).</ce:simple-para><ce:simple-para id="fspara0080" view="all">(D-H) Adult hRPE stained for SC121 (red). (D) Adult hRPE stained for MCT1 (green). (E) Human adult RPE stained for ezrin (green). hRPEs transplanted into rabbit SRS show absence of expression of ki67 (F), phosphohistone H3 (G), and caspase-3 (H). Polarized fetal and adult hRPE cells were found in TEM (I and J). Nuclei with regular chromatin were found in the basal compartment, a basal lamina ([I], large black arrowhead) had formed between the xenograft and PET carrier (black asterisks). Melanosomes (M) in multiple stages, some microvilli abutting to the atrophic neural retina (NR), and junctional structures with desmosomes (small black arrowhead) and tight junctions (red arrowhead) were discerned apically. Mitochondria (MC) were seen in the basolateral part of the cell. Detachment from cell carrier (asterisk) in (J) is a histologic processing artifact. Left images in (I) and (J) taken at 10,500× magnification; right micrographs are rectangular zone in left at 25,000×; scale bars represent 2 μm/inset 0.2 μm distance in (I) and (J).</ce:simple-para></ce:caption><ce:link locator="gr3"/></ce:figure><ce:figure id="fig4"><ce:label>Figure 4</ce:label><ce:caption id="cap0030"><ce:simple-para id="fspara0085" view="all">Effect of Systemic Immunosuppression on Fetal hRPE Transplant and Retinal Integrity</ce:simple-para><ce:simple-para id="fspara0090" view="all">(A-J) Immunosuppression was induced preoperatively in 14 animals with DXP. Controls and DXP-treated animals received an intravitreal injection of 1 to 2 mg TCA given at the end of the procedure. Animals were imaged at day 28 post-OP with cSLO infrared reflectance imaging (A and F), SD-OCT (B and G), and processed for histology (C-E and H-J) on the same day. Notice the rather continuous fetal hRPE layer on PET carriers without systemic DXP immunosuppression (C-E), whereas pigmented cells on DXP-suppressed samples appear mottled and discontinuous (H-J). By contrast, preservation of inner retinal reflectance layers on SD-OCT was possible in 3 of 11 survivors with DXP suppression. Red arrows in (C)-(E) and (H)-(J) point to putative hRPE transplant; black arrow (E) and retinal detachment in (C)-(E) are histologic processing artifacts. Scale bars, 200 μm (A, B, F, and G), 250 μm (C, E, and H), and 50 μm (J). See also <ce:cross-ref refid="mmc6" id="crosref0535">Movie S5</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr4"/></ce:figure><ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl1" frame="topbot" colsep="0" rowsep="0"><ce:label>Table 1</ce:label><ce:caption id="cap0035"><ce:simple-para id="tspara0010" view="all">All Surgical Conditions Listed According to Implant Type, Surgical Protocol, and Use of Local and/or Systemic Immunosuppression</ce:simple-para></ce:caption><tgroup cols="7"><colspec colnum="1" colname="col1"/><colspec colnum="2" colname="col2"/><colspec colnum="3" colname="col3"/><colspec colnum="4" colname="col4"/><colspec colnum="5" colname="col5"/><colspec colnum="6" colname="col6"/><colspec colnum="7" colname="col7"/><thead><row valign="bottom"><entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" rowsep="1">Implantation Protocol</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col2" nameend="col5" rowsep="1">Surgical Protocol<cross-ref refid="tblfn1" id="crosref0540"><sup loc="post">a</sup></cross-ref></entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" rowsep="1">Rabbits Used</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" rowsep="1">Donors Used</entry></row><row rowsep="1" valign="bottom"><entry xmlns="http://www.elsevier.com/xml/common/dtd">Gelatin</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">Plasmin</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">TCA</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">DXP</entry></row></thead><tbody><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd">RD only (19)<cross-ref refid="tblfn2" id="crosref0545"><sup loc="post">b</sup></cross-ref></entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">7</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd"/></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd"/><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">4</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd"/></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd"/><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">1</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd"/></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd"/><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">7</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd"/></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd">PET alone (7)</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">2</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd"/></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd"/><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">1</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd"/></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd"/><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">4</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd"/></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd">fhRPE (40)</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">2</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="6">2<cross-ref refid="tblfn3" id="crosref0550"><sup loc="post">c</sup></cross-ref></entry></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd"/><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">5</entry></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd"/><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">6</entry></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd"/><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">6</entry></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd"/><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">3</entry></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd"/><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">4</entry></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd"/><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">14</entry></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd">ahRPE (5)</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">yes</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" align="char" char=".">5</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">2<cross-ref refid="tblfn3" id="crosref0555"><sup loc="post">c</sup></cross-ref></entry></row></tbody></tgroup><ce:legend><ce:simple-para id="tspara0015" view="all">Yes/no indicates variable(s) included in particular implantation protocol. TCA refers to triamcinolone acetonide, DXP is dexamethasone phosphate, RD means (bleb) retinal detachment, PET is the polyester terephthalate cell carrier, fhRPE is fetal human retinal pigment epithelium, and ahRPE is adult human retinal pigment epithelium.</ce:simple-para></ce:legend><ce:table-footnote id="tblfn1"><ce:label>a</ce:label><ce:note-para id="ntpara0020" view="all">Surgeons: B.V.S. = 47, N.E. = 10, S.S. = 3.</ce:note-para></ce:table-footnote><ce:table-footnote id="tblfn2"><ce:label>b</ce:label><ce:note-para id="ntpara0025" view="all">There were eight rabbits treated with RD only; 11 blebs created next to another implantation side.</ce:note-para></ce:table-footnote><ce:table-footnote id="tblfn3"><ce:label>c</ce:label><ce:note-para id="ntpara0030" view="all">Cultures derived from a single donor were used for a particular implantation.</ce:note-para></ce:table-footnote></ce:table><ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl2" frame="topbot" colsep="0" rowsep="0"><ce:label>Table 2</ce:label><ce:caption id="cap0040"><ce:simple-para id="tspara0020" view="all">List of Complications Following the Implantation Procedure</ce:simple-para></ce:caption><tgroup cols="6"><colspec colnum="1" colname="col1"/><colspec colnum="2" colname="col2"/><colspec colnum="3" colname="col3"/><colspec colnum="4" colname="col4"/><colspec colnum="5" colname="col5"/><colspec colnum="6" colname="col6"/><thead><row rowsep="1" valign="bottom"><entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="2">Complications</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col2" nameend="col6">Implant Type</entry></row><row rowsep="1" valign="bottom"><entry xmlns="http://www.elsevier.com/xml/common/dtd">RD Only</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">PET Alone</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">ahRPE</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col5" nameend="col6">fhRPE</entry></row><row rowsep="1" valign="bottom"><entry xmlns="http://www.elsevier.com/xml/common/dtd">Without DXP</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">Without DXP</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">Without DXP</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">Without DXP</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">With DXP</entry></row></thead><tbody><row rowsep="1" valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col6"><bold>Ophthalmic</bold></entry></row><row valign="top" rowsep="1"><entry xmlns="http://www.elsevier.com/xml/common/dtd">Postoperative endophthalmitis</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd">Corneal epithelial defects<cross-ref refid="tblfn4" id="crosref0560"><sup loc="post">a</sup></cross-ref></entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">2/5</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">14/14</entry></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd">Retinal detachments, entry</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col2" nameend="col6">3/60</entry></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd">Posterior subcapsular cataracts (traumatic)</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col2" nameend="col6">Several cases<cross-ref refid="tblfn4" id="crosref0565"><sup loc="post">a</sup></cross-ref></entry></row><row rowsep="1" valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd">Persistent subretinal fluid</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col5" nameend="col6">2/40</entry></row><row valign="top" rowsep="1"><entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col6"><bold>Systemic</bold></entry></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd"><hsp sp="1"/>Reduction in muscle mass</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">14/14</entry></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd"><hsp sp="1"/>Slow-healing skin abrasions at hind paws</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">3/14</entry></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd">Anesthetic complications<cross-ref refid="tblfn5" id="crosref0570"><sup loc="post">b</sup></cross-ref></entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">no</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">2/14</entry></row><row valign="top"><entry xmlns="http://www.elsevier.com/xml/common/dtd"><hsp sp="1"/>Death rate</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col2" nameend="col5">9/46</entry><entry xmlns="http://www.elsevier.com/xml/common/dtd">3/14</entry></row></tbody></tgroup><ce:legend><ce:simple-para id="tspara0025" view="all">DXP is dexamethasone phosphate, RD means (bleb) retinal detachment, PET is the polyester terephthalate cell carrier, fhRPE is fetal human retinal pigment epithelium, and ahRPE is adult human retinal pigment epithelium.</ce:simple-para></ce:legend><ce:table-footnote id="tblfn4"><ce:label>a</ce:label><ce:note-para id="ntpara0035" view="all">These cases still allowed for SD-OCT and fundus imaging.</ce:note-para></ce:table-footnote><ce:table-footnote id="tblfn5"><ce:label>b</ce:label><ce:note-para id="ntpara0040" view="all">Malignant hypertension, tachypnea, and hyperthermia during recovery from anesthesia.</ce:note-para></ce:table-footnote></ce:table></ce:floats><head><ce:article-footnote><ce:note-para id="ntpara0010" view="all">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</ce:note-para></ce:article-footnote><ce:dochead id="dhead0010"><ce:textfn>Article</ce:textfn></ce:dochead><ce:title id="title0010">Human RPE Stem Cells Grown into Polarized RPE Monolayers on a Polyester Matrix Are Maintained after Grafting into Rabbit Subretinal Space</ce:title><ce:author-group id="augrp0010"><ce:author id="au1"><ce:given-name>Boris V.</ce:given-name><ce:surname>Stanzel</ce:surname><ce:cross-ref refid="aff1" id="crosref0010"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="fn1" id="crosref0015"><ce:sup loc="post">5</ce:sup></ce:cross-ref><ce:cross-ref refid="cor1" id="crosref0020"><ce:sup loc="post">∗</ce:sup></ce:cross-ref><ce:e-address type="email" id="eadd0010">stanzel@uni-bonn.de</ce:e-address></ce:author><ce:author id="au2"><ce:given-name>Zengping</ce:given-name><ce:surname>Liu</ce:surname><ce:cross-ref refid="aff1" id="crosref0025"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au3"><ce:given-name>Sudawadee</ce:given-name><ce:surname>Somboonthanakij</ce:surname><ce:cross-ref refid="aff1" id="crosref0030"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="aff2" id="crosref0035"><ce:sup loc="post">2</ce:sup></ce:cross-ref></ce:author><ce:author id="au4"><ce:given-name>Warapat</ce:given-name><ce:surname>Wongsawad</ce:surname><ce:cross-ref refid="aff1" id="crosref0040"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="aff2" id="crosref0045"><ce:sup loc="post">2</ce:sup></ce:cross-ref></ce:author><ce:author id="au5"><ce:given-name>Ralf</ce:given-name><ce:surname>Brinken</ce:surname><ce:cross-ref refid="aff1" id="crosref0050"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au6"><ce:given-name>Nicole</ce:given-name><ce:surname>Eter</ce:surname><ce:cross-ref refid="aff3" id="crosref0055"><ce:sup loc="post">3</ce:sup></ce:cross-ref></ce:author><ce:author id="au7"><ce:given-name>Barbara</ce:given-name><ce:surname>Corneo</ce:surname><ce:cross-ref refid="aff4" id="crosref0060"><ce:sup loc="post">4</ce:sup></ce:cross-ref></ce:author><ce:author id="au8"><ce:given-name>Frank G.</ce:given-name><ce:surname>Holz</ce:surname><ce:cross-ref refid="aff1" id="crosref0065"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au9"><ce:given-name>Sally</ce:given-name><ce:surname>Temple</ce:surname><ce:cross-ref refid="aff4" id="crosref0070"><ce:sup loc="post">4</ce:sup></ce:cross-ref></ce:author><ce:author id="au10"><ce:given-name>Jeffrey H.</ce:given-name><ce:surname>Stern</ce:surname><ce:cross-ref refid="aff4" id="crosref0075"><ce:sup loc="post">4</ce:sup></ce:cross-ref></ce:author><ce:author id="au11"><ce:given-name>Timothy A.</ce:given-name><ce:surname>Blenkinsop</ce:surname><ce:cross-ref refid="aff4" id="crosref0080"><ce:sup loc="post">4</ce:sup></ce:cross-ref><ce:cross-ref refid="fn1" id="crosref0085"><ce:sup loc="post">5</ce:sup></ce:cross-ref></ce:author><ce:affiliation id="aff1"><ce:label>1</ce:label><ce:textfn>Department of Ophthalmology, University of Bonn, Bonn 53127, Germany</ce:textfn></ce:affiliation><ce:affiliation id="aff2"><ce:label>2</ce:label><ce:textfn>Mettapracharak Eye Institute, Raikhing, Nakhon Pathom 73210, Thailand</ce:textfn></ce:affiliation><ce:affiliation id="aff3"><ce:label>3</ce:label><ce:textfn>Department of Ophthalmology, University of Muenster, Muenster 48149, Germany</ce:textfn></ce:affiliation><ce:affiliation id="aff4"><ce:label>4</ce:label><ce:textfn>Neural Stem Cell Institute, Rensselaer, NY 12144, USA</ce:textfn></ce:affiliation><ce:correspondence id="cor1"><ce:label>∗</ce:label><ce:text>Corresponding author</ce:text></ce:correspondence><ce:footnote id="fn1"><ce:label>5</ce:label><ce:note-para id="ntpara0015" view="all">These authors contributed equally to this work.</ce:note-para></ce:footnote></ce:author-group><ce:date-received day="19" month="7" year="2013"/><ce:date-revised day="7" month="11" year="2013"/><ce:date-accepted day="8" month="11" year="2013"/><ce:miscellaneous id="misc0010">Published: January 2, 2014</ce:miscellaneous><ce:abstract id="abs0010" view="all" class="author"><ce:section-title id="sectitle0010">Summary</ce:section-title><ce:abstract-sec id="abssec0010" view="all"><ce:simple-para id="abspara0010" view="all">Transplantation of the retinal pigment epithelium (RPE) is being developed as a cell-replacement therapy for age-related macular degeneration. Human embryonic stem cell (hESC) and induced pluripotent stem cell (iPSC)-derived RPE are currently translating toward clinic. We introduce the adult human RPE stem cell (hRPESC) as an alternative RPE source. Polarized monolayers of adult hRPESC-derived RPE grown on polyester (PET) membranes had near-native characteristics. Trephined pieces of RPE monolayers on PET were transplanted subretinally in the rabbit, a large-eyed animal model. After 4 days, retinal edema was observed above the implant, detected by spectral domain optical coherence tomography (SD-OCT) and fundoscopy. At 1 week, retinal atrophy overlying the fetal or adult transplant was observed, remaining stable thereafter. Histology obtained 4 weeks after implantation confirmed a continuous polarized human RPE monolayer on PET. Taken together, the xeno-RPE survived with retained characteristics in the subretinal space. These experiments support that adult hRPESC-derived RPE are a potential source for transplantation therapies.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class="graphical" id="abs0015" view="all"><ce:section-title id="sectitle0015">Graphical Abstract</ce:section-title><ce:abstract-sec id="abssec0015" view="all"><ce:simple-para id="abspara0015" view="all"><ce:display><ce:figure id="undfig1"><ce:link locator="fx1"/></ce:figure></ce:display></ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class="author-highlights" id="abs0020" view="all"><ce:section-title id="sectitle0020">Highlights</ce:section-title><ce:abstract-sec id="abssec0020" view="all"><ce:simple-para id="abspara0020" view="all"><ce:list id="ulist0010"><ce:list-item id="u0010"><ce:label>•</ce:label><ce:para id="p0010" view="all">Adult hRPESC-derived RPE had comparable in vitro characteristics to fetal hRPE</ce:para></ce:list-item><ce:list-item id="u0015"><ce:label>•</ce:label><ce:para id="p0015" view="all">hRPE monolayers survived 4 weeks on PET carriers under the rabbit retina</ce:para></ce:list-item><ce:list-item id="u0020"><ce:label>•</ce:label><ce:para id="p0020" view="all">Better xenograft survival may be due to the maintained hRPE cell polarity</ce:para></ce:list-item><ce:list-item id="u0025"><ce:label>•</ce:label><ce:para id="p0025" view="all">Atrophy of the retina overlaying the hRPE xenograft remains a future challenge</ce:para></ce:list-item></ce:list></ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class="teaser" id="abs0025" view="all"><ce:abstract-sec id="abssec0025" view="all"><ce:simple-para id="abspara0025" view="all">Stanzel et al. have transplanted polarized monolayers of human retinal pigment epithelium (hRPE) grown on polyester membranes derived from adult hRPE stem cells or fetal tissue under the rabbit retina. The xeno-RPE survived 4 weeks with retained cell polarity characteristics in the subretinal space. These experiments support that adult hRPESC-derived RPE are a potential source for transplantation therapies.</ce:simple-para></ce:abstract-sec></ce:abstract></head><body view="all"><ce:sections><ce:section id="sec1" view="all"><ce:section-title id="sectitle0025">Introduction</ce:section-title><ce:para id="p0030" view="all">The retinal pigment epithelium (RPE) is a cellular monolayer between the retina and the underlying choroidal vasculature. The RPE participates actively in the visual process, notably by supporting the diurnal replenishment of the photoreceptors (<ce:cross-ref refid="bib43" id="crosref0090">Strauss, 2005</ce:cross-ref>). RPE dysfunction significantly contributes to the pathophysiology of age-related macular degeneration (AMD), a leading cause of blindness (<ce:cross-ref refid="bib27" id="crosref0095">Lim et al., 2012</ce:cross-ref>). There are currently no disease-altering therapies available for the vast majority (over 85%) of AMD patients that suffer from the dry form of the disease, which is characterized by extracellular deposits termed drusen beneath the RPE and subsequent RPE atrophy in the macula. The remaining approximately 15% of patients have wet AMD, in which neovascularization invades from the choroid; for these patients, repeated intravitreal injections with antiangiogenic drugs offer a highly effective, albeit palliative, treatment (<ce:cross-ref refid="bib39" id="crosref0100">Singer et al., 2012</ce:cross-ref>). Replacement of dysfunctional submacular RPE with a cell-based therapeutic agent represents a potentially curative treatment strategy (<ce:cross-ref refid="bib3" id="crosref0105">Binder et al., 2007</ce:cross-ref>). Some previous attempts in patients have been shown to improve vision, but most were limited by immune reactions, surgical complications, late-stage disease, or lack of an adequate RPE cell source (<ce:cross-ref refid="bib41" id="crosref0110">Stanzel and Holz, 2012</ce:cross-ref>). Translocation of an autologous patch of RPE/choroid remains clinically the most popular approach, because some patients benefit from the procedure, despite its high complication rates (<ce:cross-ref refid="bib48" id="crosref0115">van Zeeburg et al., 2012</ce:cross-ref>).</ce:para><ce:para id="p0035" view="all">With the development of RPE differentiation protocols from human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) (<ce:cross-refs refid="bib15 bib23" id="crosrefs0010">Hirami et al., 2009; Klimanskaya et al., 2004</ce:cross-refs>), RPE transplantation has experienced a powerful renaissance, as scientists and clinicians envision an unlimited supply of RPE for transplantation. However, much is still not understood with regard to the physiology of stem-cell-derived RPE (<ce:cross-ref refid="bib26" id="crosref0120">Liao et al., 2010</ce:cross-ref>) and transplantation into patients is in the early stages. Pilot data from a phase I/II trial (NCT01226628 and NCT01344993) with a suspension of hESC-derived RPE injected in patients with dry AMD or Stargardt's disease suggest a favorable safety profile and some limited improvement in vision (<ce:cross-ref refid="bib37" id="crosref0125">Schwartz et al., 2012</ce:cross-ref>); further dose-escalation in this multicenter study is on-going. This is encouraging, given that prior studies using RPE cell suspensions showed they failed to survive or function on aged submacular Bruch's membrane (<ce:cross-ref refid="bib45" id="crosref0130">Sugino et al., 2011</ce:cross-ref>) and are more likely to be rejected than are RPE monolayers (<ce:cross-ref refid="bib11" id="crosref0135">Diniz et al., 2013</ce:cross-ref>).</ce:para><ce:para id="p0040" view="all">A cultured human RPE monolayer that exhibits the physiology of its native counterpart could be a valuable alternative to an RPE-cell suspension. This type of culture has been readily attained using fetal- or pluripotent-stem-cell-derived RPE. However, establishing such cultures from adult RPE has proven difficult and inconsistent, due to its propensity to undergo epithelial-mesenchymal transition (reviewed in <ce:cross-ref refid="bib7" id="crosref0140">Burke, 2008</ce:cross-ref>). We have optimized culture conditions that robustly activate a subpopulation of adult human RPE stem cells (RPESC), expand, and then differentiate them into highly pure RPE monolayers that exhibit physiological features of native RPE (<ce:cross-refs refid="bib4 bib36" id="crosrefs0015">Blenkinsop et al., 2013; Salero et al., 2012</ce:cross-refs>). This protocol allows us to explore the potential of adult RPESC-derived RPE for cell-replacement therapy. To date, we do not know which cell source will turn out to be therapeutically successful, and therefore, testing all potential candidates is important. Using a cell source derived from the adult human RPE may possess several potential advantages, such as fewer ethical concerns compared to hESC and fetal human RPE (hRPE), the possibility of routine histocompatibility leukocyte antigen matching or even autologous transplantation (using a patient's own remaining healthy RPESCs) to minimize immunosuppression, reduced proliferative potential than hESCs or human iPSCs and therefore reduced tumorigenesis risk, and reduced threat of generating abnormal cell types.</ce:para><ce:para id="p0045" view="all">RPE monolayers grown on cell carriers would facilitate surgical handling and long-term functionality by substituting some or all of the functions of the aged Bruch's membrane (<ce:cross-ref refid="bib3" id="crosref0145">Binder et al., 2007</ce:cross-ref>). Coimplantation of differentiated RPE monolayers on a substrate has been attempted in animal models only in a few instances and with limited success (<ce:cross-refs refid="bib2 bib11 bib31" id="crosrefs0020">Bhatt et al., 1994; Diniz et al., 2013; Nicolini et al., 2000</ce:cross-refs>). Improvements would involve employing a biocompatible matrix that exhibits minimal deformation after transplantation, longer-term assessment postsurgery, and use of a large-eyed animal model for better assessment of surgical technique.</ce:para><ce:para id="p0050" view="all">We have previously reported on a method and instrumentation to deliver ultrathin rigid-elastic cell carriers (polyester [PET]) into the subretinal space (SRS) of rabbits (<ce:cross-ref refid="bib42" id="crosref0150">Stanzel et al., 2012</ce:cross-ref>). Here, we demonstrate this technology can be used to deliver monolayers of human RPE on permeable polyester carriers into the SRS of the rabbit. Notably, we find RPE isolated from adult cadaver donors can expand 20-fold and survive as a polarized RPE monolayer for 1 month after transplantation, therefore representing a clinically relevant RPE cell source. Transplants were followed with state-of-the-art ophthalmic imaging technology, including spectral domain optical coherence tomography (SD-OCT), confocal scanning-laser ophthalmoscopy (cSLO), color funduscopic photography, and histology. In addition, the influence of local and systemic immunosuppression on retinal tissue alterations following xenografting was evaluated.</ce:para></ce:section><ce:section id="sec2" view="all"><ce:section-title id="sectitle0030">Results</ce:section-title><ce:section id="sec2.1" view="all"><ce:section-title id="sectitle0035">Preparation and Characterization of the RPE-Carrier Monolayers</ce:section-title><ce:para id="p0055" view="all">Adult human RPESC (hRPESC)-derived RPE and fetal hRPE monolayers were compared for their growth characteristics on the carrier PET material. Fetal hRPE cells seeded at 2 × 10<ce:sup loc="post">5</ce:sup> cells/cm<ce:sup loc="post">2</ce:sup> on PET inserts formed uniform, hexagonal monolayers by 2 weeks postconfluence, which repigmented by 6-8 weeks (<ce:cross-ref refid="fig1" id="crosref0155">Figure 1</ce:cross-ref><ce:float-anchor refid="fig1"/>A). Cultures were used for transplantation at 2 to 3 months postconfluence, when transepithelial electrical resistance (TER) values ranged from 737-1415 Ω<ce:sup loc="post">∗</ce:sup>cm<ce:sup loc="post">2</ce:sup>, mean 1244 ± 161 Ω<ce:sup loc="post">∗</ce:sup>cm<ce:sup loc="post">2</ce:sup> (n = 60), and 514-776 Ω<ce:sup loc="post">∗</ce:sup>cm<ce:sup loc="post">2</ce:sup>, mean 657 ± 60 Ω<ce:sup loc="post">∗</ce:sup>cm<ce:sup loc="post">2</ce:sup> (n = 60), from two different donor cultures (<ce:cross-ref refid="fig1" id="crosref0160">Figure 1</ce:cross-ref>C). Fetal RPE cultured in this manner shows morphology and gene/protein expression similar to native RPE, thereby serving as a reference for adult-stem-cell-derived RPE (<ce:cross-ref refid="bib26" id="crosref0165">Liao et al., 2010</ce:cross-ref>).</ce:para><ce:para id="p0060" view="all">About 5 × 10<ce:sup loc="post">6</ce:sup> adult hRPEs were typically isolated per donor. During the first month, the cultures went through 2-4 population doublings, thus expanding to approximately 2.5 × 10<ce:sup loc="post">7</ce:sup>. We then seeded adult hRPE onto PET inserts at 1 × 10<ce:sup loc="post">5</ce:sup> cells/cm<ce:sup loc="post">2</ce:sup> until they formed uniform, hexagonal monolayers 4 weeks postconfluence, expanding another 2-4 more times during this passage. As a result, after 3 months, the adult RPESCs and their progeny had expanded 20-fold, and from one donor, we obtained approximately 1 × 10<ce:sup loc="post">8</ce:sup> RPEs (<ce:cross-ref refid="fig1" id="crosref0170">Figure 1</ce:cross-ref>B).</ce:para><ce:para id="p0065" view="all">We monitored adult hRPE characteristics during the culture period by measuring TER, gene expression, and polarized protein localization immunohistochemically. After 2 months on the PET substrate, when the adult hRPE monolayers exhibited a uniform, polygonal shape, TER was measured regularly to confirm development of tight junctions (<ce:cross-ref refid="fig1" id="crosref0175">Figure 1</ce:cross-ref> and <ce:cross-ref refid="app2" id="crosref0180">Figure S1</ce:cross-ref> available online) and were found to range between 210-339 Ω<ce:sup loc="post">∗</ce:sup>cm<ce:sup loc="post">2</ce:sup> at 8 weeks after plating, with a mean of 308 ± 18.7 Ω<ce:sup loc="post">∗</ce:sup>cm<ce:sup loc="post">2</ce:sup> (n = 12) and mean 240 ± 24.9 Ω<ce:sup loc="post">∗</ce:sup>cm<ce:sup loc="post">2</ce:sup> (n = 12) from respective donor cultures.</ce:para><ce:para id="p0070" view="all">Gene-expression profiling was conducted using RNA extracted from adult hRPE tissue at the time of dissection (referred to as native) versus RNA extracted from adult hRPE after 2 months on PET (<ce:cross-ref refid="fig1" id="crosref0185">Figure 1</ce:cross-ref>E; n = 5 donors). Cultured adult hRPE exhibited largely similar but sometimes higher expression of RPE markers compared to the native tissue.</ce:para><ce:para id="p0075" view="all">To determine purity and polarization of the adult hRPE cultures, we performed immunostaining using characteristic RPE markers, assessed by confocal imaging (<ce:cross-ref refid="fig1" id="crosref0190">Figure 1</ce:cross-ref>F). Claudin-19 was present along the apical-lateral membrane along with the tight-junction complex protein ZO-1, indicating the existence of a functional epithelial barrier (<ce:cross-ref refid="bib32" id="crosref0195">Peng et al., 2011</ce:cross-ref>). Ezrin, a membrane-associated protein involved in cytoskeletal organization, was found preferentially in RPE microvilli (<ce:cross-ref refid="bib5" id="crosref0200">Bonilha et al., 1999</ce:cross-ref>). The visual cycle proteins cellular retinaldehyde-binding protein (CRALBP) and RPE65 (<ce:cross-refs refid="bib6 bib34" id="crosrefs0025">Bunt-Milam and Saari, 1983; Redmond et al., 1998</ce:cross-refs>) were localized in the cytoplasm, as expected. Monocarboxylate transporter 1 (MCT1) was present apically (<ce:cross-ref refid="bib33" id="crosref0205">Philp et al., 1998</ce:cross-ref>).</ce:para><ce:para id="p0080" view="all">The appropriate localization of these proteins, combined with the gene-expression pattern and TER measurements, were similar to native RPE, demonstrating appropriate physiology of the adult hRPE monolayers to be used for transplantation.</ce:para></ce:section><ce:section id="sec2.2" view="all"><ce:section-title id="sectitle0040">Cultured hRPE Xenografted into Rabbit SRS</ce:section-title><ce:para id="p0085" view="all">hRPE cultures grown on PET membranes were trephined to generate bullet-shaped implants approximately 1.1 mm × 2.2 mm (∼6-8000 cells), as described previously (<ce:cross-ref refid="bib42" id="crosref0210">Stanzel et al., 2012</ce:cross-ref>). Subretinal implantation of 45 such constructs was evaluated, which included 40 fetal and five adult human RPE monolayer implants (<ce:cross-ref refid="tbl1" id="crosref0215">Table 1</ce:cross-ref><ce:float-anchor refid="tbl1"/>). The RPE monolayer transplant was placed cell-carrier down on intact host RPE within the SRS (<ce:cross-ref refid="fig2" id="crosref0220">Figures 2</ce:cross-ref><ce:float-anchor refid="fig2"/> and <ce:cross-ref refid="fig3" id="crosrefs0030">3</ce:cross-ref><ce:float-anchor refid="fig3"/>; <ce:cross-ref refid="mmc2" id="crosref0225">Movie S1</ce:cross-ref>). In addition, controls with bleb retinal detachments alone (bRD) (n = 19) and PET carrier-only implants (n = 7) were performed to differentiate surgical trauma from biological effects (<ce:cross-ref refid="app2" id="crosref0230">Figure S2</ce:cross-ref>; <ce:cross-ref refid="mmc3" id="crosref0235">Movie S2</ce:cross-ref>).</ce:para><ce:para id="p0090" view="all">On first postoperative exam (days 3-5), a white retinal opacity overlying the hRPE implant was seen on fundus photography, along with occasional triamcinolone crystals trapped around the retinotomy site. The whitish opacity was subsequently lost in both hRPE implant types, with all remaining follow-up exams (beyond 1 week postoperation [post-OP]) showing a steep edge around the implant periphery (<ce:cross-ref refid="fig2" id="crosref0240">Figure 2</ce:cross-ref>A for fetal and <ce:cross-ref refid="fig2" id="crosrefs0035">2</ce:cross-ref>C for adult; <ce:cross-ref refid="mmc4" id="crosref0245">Movies S3</ce:cross-ref> and <ce:cross-ref refid="mmc5" id="crosref0250">S4</ce:cross-ref>).</ce:para><ce:para id="p0095" view="all">On the first SD-OCT follow-up (at 3-5 days post-OP), the neural retina above the fetal and adult hRPE implant showed an increased overall thickness, with loss of typical retinal reflectance layering, as well as slowed clearance of subretinal fluid from the bRD (<ce:cross-ref refid="fig2" id="crosref0255">Figure 2</ce:cross-ref>, B1 and D1, respectively). Xenografted adult hRPE on PET followed similar, albeit slightly delayed, patterns as seen with the fetal transplants. Notably, however, the retina was typically adherent to both hRPE implant variants on the apical surface, and the implant plus carrier appeared apposed to the host RPE layer on the basal surface. The choroidal vascular layer underneath both hRPE implant types appeared to have less reflectivity and slightly increased volume compared to adjacent regions on SD-OCT at all time points. After 1 week, an apparent retinal tissue loss over the implant center was discernible on SD-OCT (<ce:cross-ref refid="fig2" id="crosref0260">Figure 2</ce:cross-ref>). The findings were well correlated with color fundus photography. Following the initial retinal thinning seen after the first week, the retina remained stable for the duration of the follow-up examinations (<ce:cross-ref refid="fig2" id="crosref0265">Figure 2</ce:cross-ref>; <ce:cross-ref refid="mmc4" id="crosref0270">Movies S3</ce:cross-ref> and <ce:cross-ref refid="mmc5" id="crosref0275">S4</ce:cross-ref>).</ce:para><ce:para id="p0100" view="all">On infrared cSLO, a distinct reflectivity halo appeared to surround the PET alone as well as the hRPE implants, which correlated with a loss of outer retinal SD-OCT bands (<ce:cross-ref refid="fig2" id="crosref0280">Figure 2</ce:cross-ref>A). The halo diameter was smaller than the original size of the bRD. PET-only implants produced a smaller halo than hRPE xenografts.</ce:para><ce:para id="p0105" view="all">We asked whether encapsulating the graft in additional materials would help the surgical delivery and potentially reduce the retinal thinning. Temporary graft encapsulation with thermosensitive gelatin and/or plasmin-assisted vitrectomy, however, was found to cause more aggressive retinal destruction and choroidal engorgement on SD-OCT compared to unaided implantation of fetal hRPE/PET implants (<ce:cross-ref refid="app2" id="crosref0285">Figure S2</ce:cross-ref>). In contrast, we found that all these negative effects were ameliorated through 1 to 2 mg intravitreal triamcinolone (TCA) injection at the end of the surgery. This long-acting synthetic corticosteroid is routinely given intraocularly to reduce immune responses. Ophthalmic and systemic complications related to the implantation procedure are summarized in <ce:cross-ref refid="tbl2" id="crosref0290">Table 2</ce:cross-ref><ce:float-anchor refid="tbl2"/>.</ce:para></ce:section><ce:section id="sec2.3" view="all"><ce:section-title id="sectitle0045">Characterization of hRPE Xenografts by Immunolabeling and Transmission Electron Microscopy</ce:section-title><ce:para id="p0110" view="all">Animals were sacrificed and perfusion-fixed at 4 weeks posttransplantation and the recovered grafts then sectioned. Microscopic inspection revealed that the grafts had been maintained as a largely intact and continuous cell monolayer. A positive pan-cytokeratin (pCK) signal, an established RPE marker, was confirmed for fetal and adult hRPE monolayers (<ce:cross-ref refid="fig3" id="crosref0295">Figures 3</ce:cross-ref>A and 3C). Additional pCK reactivity was seen "underneath" the cell carrier, likely from host RPE. Moreover, fetal and adult hRPE on PET carriers stained positively for the human-specific marker SC121, confirming survival of human RPE for 1 month as a monolayer (<ce:cross-ref refid="fig3" id="crosref0300">Figure 3</ce:cross-ref>). Costaining of SC121 with an antibody to MCT1 and Ezrin, both apical membrane markers, further confirmed that the RPE were (still) polarized (<ce:cross-ref refid="fig3" id="crosref0305">Figure 3</ce:cross-ref>). SC121<ce:sup loc="post">+</ce:sup> RPE transplants were negative for the expression of the cell-cycle marker ki67, the proliferation marker phosphohistone H3, and for the apoptotic marker caspase-3 (<ce:cross-ref refid="fig3" id="crosref0310">Figures 3</ce:cross-ref>F-3H), indicating absence of proliferation and apoptosis. We estimated the total human RPE cell survival to be approximately 95% after 1 month by using the SC121 positivity; we measured the total length of the carrier and the length of SC121 stain and calculated the percent coverage of SC121 over the total carrier length. On transmission electron micrography (TEM), polarized RPE cells were observed on the PET carriers from both fetal and adult transplants (<ce:cross-ref refid="fig3" id="crosrefs0040">Figures 3</ce:cross-ref>I and 3J). These results confirm survival of polarized human RPE from fetal and adult donors xenografted into rabbit SRS over 4 weeks.</ce:para></ce:section><ce:section id="sec2.4" view="all"><ce:section-title id="sectitle0050">Effect of Systemic Immunosuppression on Fetal RPE Transplant and Retinal Integrity</ce:section-title><ce:para id="p0115" view="all">We conducted a consecutive series of transplants with preoperative, systemically immunosuppressed animals, aiming to improve preservation of the neural retina above the fetal RPE monolayer xenograft. Systemic dexamethasone (DXP) immunosuppression (2.5-3 mg/kg/day intramuscularly) in 14 rabbits resulted in inconsistent maintenance of the inner retinal layers (3 of 14), yet always leading to an atrophy of the outer photoreceptor cell layer above the hRPE implant (<ce:cross-ref refid="fig4" id="crosref0315">Figure 4</ce:cross-ref><ce:float-anchor refid="fig4"/>; <ce:cross-ref refid="mmc6" id="crosref0320">Movie S5</ce:cross-ref>). The surviving RPE cells appeared pleiomorphic and scattered into patches on the PET carrier. By contrast, animals that did not receive systemic immunosuppression, but were treated with TCA injection, had a complete disarray and/or absence of all retinal layers above the implant, but the hRPE monolayer was much better preserved.</ce:para><ce:para id="p0120" view="all">Remarkably, on SD-OCT, near-normal choroidal reflectivity patterns were seen underneath the fetal hRPE implant as early as 1 week postimplantation in most (9 of 14) DXP-suppressed animals (<ce:cross-ref refid="fig4" id="crosref0325">Figure 4</ce:cross-ref>G), similar to areas with normal retina or PET carrier-only implants. Nonimmunosuppressed rabbits showed a distinctly diminished reflectivity and locally increased volume within the choroid underneath the fetal hRPE grafts, with no apparent histomorphologic correlate at 4 weeks postimplantation for these choroidal changes on SD-OCT. Perhaps mediated through suppression of all peripheral blood leukocytes (<ce:cross-ref refid="bib20" id="crosref0330">Jeklova et al., 2008</ce:cross-ref>), systemic DXP seemed to effectively dampen choroidal immune reactions underneath fetal hRPE grafts. See <ce:cross-ref refid="tbl2" id="crosref0335">Table 2</ce:cross-ref> for DXP-related complications.</ce:para><ce:para id="p0125" view="all">In summary, systemic immunosuppression with DXP resulted in poor survival of fetal hRPE transplants, whereas local administration of TCA intravitreally improved surgical outcome.</ce:para></ce:section></ce:section><ce:section id="sec3" view="all"><ce:section-title id="sectitle0055">Discussion</ce:section-title><ce:para id="p0130" view="all">The advances in hESC, iPSC, and RPESC technology have opened new opportunities to test whether transplantation of RPE into the SRS of patients with RPE-related diseases might restore some of the lost RPE function, ultimately leading to preservation or restoration of vision. One major unknown is whether these RPE cells can survive as a monolayer in the SRS and maintain their identity. Here, we demonstrate that polarized human fetal and adult RPE monolayers cultured on a polyester matrix can survive grafting into the rabbit SRS, thus resolving many of the current roadblocks concerning clinical RPE monolayer transplantation.</ce:para><ce:para id="p0135" view="all">RPESCs isolated from elderly donor eyes were expanded and successfully differentiated to generate approximately 1 × 10<ce:sup loc="post">8</ce:sup> RPE per donor. Considering 5 × 10<ce:sup loc="post">4</ce:sup> or fewer RPE cells are required to cover the macula, using adult hRPE from one donor has the potential to treat many hundreds of patients. While promising, the expansion potential of adult hRPE is limited and the generation of multiple banks would be required to enable treatment of the millions of patients suffering from eye diseases such as AMD. One potential alternative to adult hRPE thought to have an unlimited expansion potential is hESC- and iPSC-derived RPE. However, a recent study shows changes in the physiology of iPSC-RPE after serial passaging (<ce:cross-ref refid="bib40" id="crosref0340">Singh et al., 2013</ce:cross-ref>); therefore, the difference between these lines and adult hRPE with regard to their expansion capabilities may not be significant.</ce:para><ce:para id="p0140" view="all">The adult RPESC-derived RPE cultures were shipped live from the US to the German surgical team. Despite the transportation stress, the cultures soon exhibited morphology and TER values comparable to preshipment levels. Successful shipment of cultured implants between clinical-grade cell production to distant surgical sites should therefore be possible, hinting at the potential rapid spread of therapy adoption. Very little is known regarding optimal conditions for RPE implant shipment, and our studies have established conditions for successful cultured RPE monolayer transport.</ce:para><ce:para id="p0145" view="all">Here, we show that, similar to fetal hRPE (<ce:cross-ref refid="bib26" id="crosref0345">Liao et al., 2010</ce:cross-ref>), adult hRPE cultures can exhibit characteristics similar to native adult human RPE. Cultured adult hRPE had TER measurements that were actually closer to native adult RPE than cultured fetal hRPE. These two RPE culture systems were developed independently in separate laboratories and as such used slightly different culture methods. More detailed comparison is warranted between human native fetal and adult tissues and RPE cultures made from these cells in order to determine the optimal cells for a particular target patient population.</ce:para><ce:para id="p0150" view="all">After implantation into the rabbit eye, both fetal and adult RPE grown on a biocompatible, permeable polyester matrix survived and maintained key properties. Moreover, we observed no occurrence of scarring on the retinal surface (due to proliferative vitreoretinopathy) or graft proliferation. The fact that both fetal and adult hRPE behaved similarly suggests these two distinct RPE populations share comparable features with regard to transplantation.</ce:para><ce:para id="p0155" view="all">We tested whether gelatin and plasmin could facilitate implant placement in the SRS but found survival of the RPE cells adversely affected. Gelatin and plasmin have been reported to be proinflammatory (<ce:cross-refs refid="bib17 bib24 bib49" id="crosrefs0045">Huang et al., 1998; Lai, 2009; Verstraeten et al., 1993</ce:cross-refs>), which may explain the reduced and patchy RPE coverage on PET carriers we observed in these cases at 4 weeks postimplantation (data not shown).</ce:para><ce:para id="p0160" view="all">Remarkably, fetal and adult hRPE monolayers survived without systemic immunosuppression, which agrees with a previous fetal hRPE carrier transplant study (<ce:cross-ref refid="bib2" id="crosref0350">Bhatt et al., 1994</ce:cross-ref>). Our study now extends these findings to adult hRPE. Importantly, we demonstrate that adult hRPESC-derived RPE monolayers maintained cell-polarity markers up to 4 weeks postgrafting. A significant body of evidence now suggests that the RPE actively modulates the immune system via cell-surface and secretory mechanisms; that is, it has qualities of an immune-privileged tissue (<ce:cross-ref refid="bib46" id="crosref0355">Sugita, 2009</ce:cross-ref>). Like other epithelial cells, RPEs in single-cell suspension lose their polarized cytoskeletal and membrane-protein distribution, likely becoming more susceptible to immune rejection. Consistent with this, single-cell suspensions of RPE do not survive when transplanted underneath the kidney capsule, whereas intact RPE sheets do (<ce:cross-ref refid="bib52" id="crosref0360">Wenkel and Streilein, 2000</ce:cross-ref>). Suspensions of human fetal RPE transplanted into the rabbit SRS showed cellular infiltration with subsequent destruction (<ce:cross-ref refid="bib13" id="crosref0365">Gabrielian et al., 1999</ce:cross-ref>). In contrast, unsupported, cultured patches of fetal human RPE transplanted into albino rabbits seemed to survive 1 month, after which they showed signs of rejection (<ce:cross-ref refid="bib38" id="crosref0370">Sheng et al., 1995</ce:cross-ref>). Hence, it appears that maintaining RPE intercellular connectivity, i.e., as monolayers, is beneficial to prevent rejection. We therefore speculate that survival of these fetal and adult RPE xenografts in rabbits is promoted by their maintenance as a polarized monolayer. It is possible that xenograft survival in our model was also facilitated due to implant placement above an intact host RPE, because the SRS itself has also been considered an immune privileged site (<ce:cross-ref refid="bib21" id="crosref0375">Jiang et al., 1994</ce:cross-ref>). Destruction of the RPE by sodium iodate abolishes such immune privilege (<ce:cross-ref refid="bib51" id="crosref0380">Wenkel and Streilein, 1998</ce:cross-ref>). However, we note that, in the study by <ce:cross-ref refid="bib2" id="crosref0385">Bhatt et al. (1994)</ce:cross-ref> in which fetal hRPE cell monolayers survived 6 weeks, they removed the host RPE prior to transplantation, indicating that graft survival was not due to the host RPE layer creating an immune- privileged SRS.</ce:para><ce:para id="p0165" view="all">We found that systemic DXP immunosuppression was less successful than local administration of TCA but view the translational value of these findings cautiously. Little is known about differences in immune rejection between RPE xenografts, as done here, and allografts as contemplated in patients. To our knowledge, there have been no direct comparisons of these two scenarios, and we note that species and animal strain differences may also be relevant. Attempts to compare the immune responses in the SRS with other xenograft models may not be appropriate because of the unique immunologic environment underneath the retina. In RPE allografts, major histocompatibility complex II expression by the RPE (and its subsequent recognition by T cells; <ce:cross-ref refid="bib53" id="crosref0390">Zhang and Bok, 1998</ce:cross-ref>), along with cytokine production (interleukin [IL]-6 and interferon γ) have been implicated in rejection (<ce:cross-ref refid="bib12" id="crosref0395">Enzmann et al., 2000</ce:cross-ref>). In contrast, RPE xenografts in rat or rabbit elicit macrophage infiltration and subsequent destruction (<ce:cross-refs refid="bib8 bib13" id="crosrefs0050">Carr et al., 2009; Gabrielian et al., 1999</ce:cross-refs>). Cytokines (IL-1 and IL-6) have also been implicated in such a reaction (<ce:cross-ref refid="bib1" id="crosref0400">Abe et al., 1999</ce:cross-ref>). (Thymic) lymphocyte infiltration has not been demonstrated in more than 20 published studies on RPE xenografts, yet both cyclosporine and tacrolimus, which are thought to suppress T-cell-mediated rejection, showed some efficacy in delaying xenograft rejection in rabbits (<ce:cross-refs refid="bib25 bib50" id="crosrefs0055">Lai et al., 2000; Wang et al., 2002</ce:cross-refs>). Cyclosporine has erratic plasma levels (thus requiring frequent serum measurements) and does not prevent allo- or xenograft rejection of an RPE (suspension) in rats or rabbits (<ce:cross-refs refid="bib8 bib25" id="crosrefs0060">Carr et al., 2009; Lai et al., 2000</ce:cross-refs>), thus questioning its usefulness. Tacrolimus has similar mechanisms of action but greater likelihood of toxic side effects. In an attempt to ameliorate negative retinal changes, we chose to administer DXP, as it predictably suppresses all peripheral leukocyte lineages in the rabbit (<ce:cross-ref refid="bib20" id="crosref0405">Jeklova et al., 2008</ce:cross-ref>). The adverse effect of DXP that we observed on xenograft survival was unexpected but perhaps mediated through the RPE glucocorticoid receptor, which promotes RPE proliferation (<ce:cross-ref refid="bib14" id="crosref0410">He et al., 1994</ce:cross-ref>). Taken together, no ideal, evidence-based immunosuppression protocol exists at present for hRPE xenograft models, but our data indicate that intravitreal TCA allows hRPE survival for at least 1 month, indicating that it could be valuable for longer-term studies.</ce:para><ce:para id="p0170" view="all">Carrier implantation into the SRS with or without hRPE resulted in a degenerated retina immediately above the implant. The cause is not clear and might be multifactorial. Despite reports to the contrary (<ce:cross-ref refid="bib47" id="crosref0415">Szurman et al., 2006</ce:cross-ref>), we believe that the bRD is unlikely to cause retinal degeneration, because we found that producing a similar bleb without subsequent insertion of a carrier results in minimal damage to photoreceptors and negligible retinal degeneration, a finding supported by others (<ce:cross-ref refid="bib19" id="crosref0420">Ivert et al., 2002</ce:cross-ref>). The rabbit retina is merangiotic, meaning only part of the inner retina is supplied by retinal vessels and is therefore more dependent on the choriocapillaris for all metabolic needs compared to holangiotic species that possess a retinal vasculature that penetrates throughout the inner retina, i.e., humans and rats. Because we placed a 10-μm-thick device between the photoreceptors and the RPE, we disrupted this normally intimidate intercellular relationship with a barrier, which likely led secondarily to the observed outer retinal degeneration. Similar observations have been made using retinal chip implants, where impermeable variants of the implants result in atrophy of photoreceptor cell layers (<ce:cross-ref refid="bib30" id="crosref0425">Montezuma et al., 2006</ce:cross-ref>).</ce:para><ce:para id="p0175" view="all">Porosity of cell carriers seems to play a crucial role in maintaining neural retinal health and layering, as implantation of an acellular PET carrier with 3.0 μm diameter pores results in significantly better preservation of outer retinal layers compared to a PET carrier with smaller, 0.4 μm diameter pores (B.V.S., Z.L., R.B., and F.G.H., unpublished data). However, other than a small study by <ce:cross-ref refid="bib29" id="crosref0430">Lu et al. (2012)</ce:cross-ref>, carrier membranes with optimal porosity for retinal preservation and permissive to RPE culture were not systematically evaluated to our knowledge. hRPE on PET carriers xenografted into the SRS resulted in initial retinal edema followed by a dramatic atrophy of all overlying retinal layers within 1 week. Such a pattern was clearly different from carrier-only controls, where only the outer retinal layers degenerated. RPE-transplant-induced retinal "melting" (<ce:cross-refs refid="bib10 bib35" id="crosrefs0065">Del Priore et al., 2001; Rezai et al., 2000</ce:cross-refs>) or photoreceptor destruction (<ce:cross-refs refid="bib11 bib53" id="crosrefs0070">Diniz et al., 2013; Zhang and Bok, 1998</ce:cross-refs>) has been observed by others and remains an unsolved problem in RPE xenotransplantation (<ce:cross-ref refid="bib9" id="crosref0435">da Cruz et al., 2007</ce:cross-ref>). Our work indicates that, rather than surgical trauma, it is the configuration of the subretinal implants themselves which cause the observed retinal degeneration. Optimization of RPE cell carriers to better mimic physiologic Bruch's membrane is an important subject and is currently being explored by us and many others (<ce:cross-refs refid="bib28 bib18 bib22 bib44" id="crosrefs0075">Liu et al., 2013; Hynes and Lavik, 2010; Kearns et al., 2012; Subrizi et al., 2012</ce:cross-refs>). Reducing such retinal degeneration after subretinal hRPE engraftment in rabbit SRS will improve the use of the rabbit as a cost-effective, large-eyed animal model. Future work will focus on identifying an appropriate cell carrier that more closely mimics the precious relationship between the outer retinal layer and the choriocapillaris.</ce:para></ce:section><ce:section id="sec4" role="materials-methods" view="all"><ce:section-title id="sectitle0060">Experimental Procedures</ce:section-title><ce:section id="sec4.1" view="all"><ce:section-title id="sectitle0065">RPE Cultures</ce:section-title><ce:section id="sec4.1.1" view="all"><ce:section-title id="sectitle0070">Fetal RPE</ce:section-title><ce:para id="p0180" view="all">Permission to work with human RPE was obtained from the Ethics Committee of the University of Bonn. Two pairs of fetal human eyes at 19<ce:sup loc="post">th</ce:sup> and 20<ce:sup loc="post">th</ce:sup> week of gestation were obtained from Advanced Bioscience Resources. The tissues were transported in CO<ce:inf loc="post">2</ce:inf>-independent media (Invitrogen) supplemented with 5% normal calf serum and 100 IU penicillin/100 μg streptomycin on ice and were processed within 48 hr postenucleation. RPE cells were isolated, expanded in low calcium media, and subsequently differentiated on uncoated 10-μm-thick polyester Transwell (PET) inserts (Corning Life Sciences catalog number 3470) according to a prior protocol (<ce:cross-ref refid="bib16" id="crosref0440">Hu and Bok, 2001</ce:cross-ref>).</ce:para></ce:section><ce:section id="sec4.1.2" view="all"><ce:section-title id="sectitle0075">Adult RPE</ce:section-title><ce:para id="p0185" view="all">The method for adult RPE culture followed our prior publication (<ce:cross-ref refid="bib4" id="crosref0445">Blenkinsop et al., 2013</ce:cross-ref>). Briefly, cadaver donor globes within 36 hr postmortem were dissected, the vitreous and retina removed, and the posterior eye-cup rinsed with calcium- and magnesium-free PBS, and then incubated in 1% dispase (2.4 IU/ml; Sigma-Aldrich catalog number D4818) for 45 min at 37°C. Sheets of RPE were gently scraped off Bruch's membrane and then layered onto Dulbecco's modified Eagle's medium (DMEM)/F12 supplemented with 10% fetal bovine serum (FBS) and with 10% sucrose. After 10 min, the lower fraction containing RPE sheets was collected, centrifuged at 285 g for 5 min, resuspended in modified DMEM/F12 (see <ce:cross-ref refid="app2" id="crosref0450">Table S1</ce:cross-ref>) supplemented with 15% FBS, and plated to cover roughly 50% of the well coated with placental extracellular matrix (BD Biosciences). The culture medium was changed every 2 to 3 days, with a gradual decrease in FBS from 15% down to 2% by 2 weeks. RPE sheets attached and grew to confluence within 2 weeks and were then passaged, plated into coated PET inserts (described above), and cultured for another 2 months, changing the medium two to three times weekly.</ce:para></ce:section></ce:section><ce:section id="sec4.2" view="all"><ce:section-title id="sectitle0080">Transepithelial Electrical Resistance Measurements</ce:section-title><ce:para id="p0190" view="all">Followed standardized methods described in the <ce:cross-ref refid="app2" id="crosref0455">Supplemental Experimental Procedures</ce:cross-ref>.</ce:para></ce:section><ce:section id="sec4.3" view="all"><ce:section-title id="sectitle0085">Quantitative PCR</ce:section-title><ce:para id="p0195" view="all">Followed standardized methods described in the <ce:cross-ref refid="app2" id="crosref0460">Supplemental Experimental Procedures</ce:cross-ref>.</ce:para></ce:section><ce:section id="sec4.4" view="all"><ce:section-title id="sectitle0090">Preparation of Implants</ce:section-title><ce:para id="p0200" view="all">Adult hRPE cells isolated from two donors (72-year-old and 71-year-old females) cultured on PET inserts were shipped on wet ice with a commercial courier (<ce:inter-ref xlink:href="http://www.biocair.com" id="intref0010" xlink:type="simple">http://www.biocair.com</ce:inter-ref>) from Rensselaer, NY to Bonn, Germany within 24 hr. The cultures were left to recover in the incubator at 37°C, 5% CO<ce:inf loc="post">2</ce:inf> for 1 week until transplantation. The TER values immediately prior to implantation were around 220 and 315 Ω<ce:sup loc="post">∗</ce:sup>cm<ce:sup loc="post">2</ce:sup> for the respective donor cultures.</ce:para><ce:para id="p0205" view="all">Acellular and RPE-seeded implants were trephined from above PET membranes using a custom-made, bullet-shaped trephine, as described previously (<ce:cross-ref refid="bib42" id="crosref0465">Stanzel et al., 2012</ce:cross-ref>). RPE on the cut carriers were rinsed three times with calcium- and magnesium-containing Hank's balanced salt solution (HBSS) immediately prior to implantation. The implant dimensions were approximately 2.2 × 1.1 mm, accommodating approximately 6-8000 cells. Prior to implantation, some membranes with and without cultured RPE were encapsulated in sterile filtered 15% porcine gelatin, bloom index 100 (Sigma-Aldrich catalog number G6144).</ce:para></ce:section><ce:section id="sec4.5" view="all"><ce:section-title id="sectitle0095">Rabbit Transplantation</ce:section-title><ce:para id="p0210" view="all">Sixty female chinchilla bastard rabbits weighing 2-2.5 kg (Charles River Laboratories) were utilized in experiments, which are summarized in <ce:cross-ref refid="tbl1" id="crosref0470">Table 1</ce:cross-ref>. All procedures were approved by the state regulatory authorities of North Rhine-Westphalia (LANUV 84-02.04.2011.A130). Animals were kept in a specialized facility with temperatures between 20 and 25°C and exposure to regular daylight, in standardized individual cages with free access to food and water.</ce:para><ce:para id="p0215" view="all">The surgical technique was further refined from our previously published protocol (<ce:cross-ref refid="bib42" id="crosref0475">Stanzel et al., 2012</ce:cross-ref>; <ce:cross-ref refid="mmc2" id="crosref0480">Movie S1</ce:cross-ref>). In brief, rabbits were anesthetized by intramuscular injection of 65 mg/kg ketamine and 5 mg/kg xylazine and pupils dilated with 2.5% phenylephrine and 1% tropicamide eye drops. Eleven of 60 rabbits received an intravitreal injection of 1 U homologous rabbit plasmin in HBSS 1 hr prior to starting the procedure. Following partial surgical removal of the vitreous (two-port core-vitrectomy), a small bRD was gently raised with 25-30 μl HBSS via a 41G Teflon cannula (DORC catalog number 1270.EXT) and Hamilton syringe, thereby expanding the SRS for surgical maneuvers. Intraocular pressure was set for 30 mmHg and was consistently associated with a facile bRD induction, as compared to 20 or &gt;50 mmHg.</ce:para><ce:para id="p0220" view="all">The implant was then passed with the custom delivery instrument from the vitreous cavity through an enlarged incision in the retina into the SRS. RPE monolayer transplants were placed cell-carrier-side down on intact host RPE, so that the xenografted RPE faced the photoreceptors (<ce:cross-ref refid="mmc2" id="crosref0485">Movie S1</ce:cross-ref>). Only the right eye was used for experimentation, and one implant was placed per eye.</ce:para></ce:section><ce:section id="sec4.6" view="all"><ce:section-title id="sectitle0100">Immunosuppression</ce:section-title><ce:section id="sec4.6.1" view="all"><ce:section-title id="sectitle0105">Local</ce:section-title><ce:para id="p0225" view="all">Most rabbits received an intravitreal injection of 1 to 2 mg preservative-free TCA at the end of the surgical procedure (see <ce:cross-ref refid="tbl1" id="crosref0490">Table 1</ce:cross-ref>). To control wound healing at the ocular surface, dexamethasone 1 mg/g, neomycin sulfate 3,500 IU/g, polymyxin B sulfate 6,000 IU/g ointment (Isoptomax, Alcon Pharma) was applied twice daily for 1 week postoperative onto the ocular surface.</ce:para></ce:section><ce:section id="sec4.6.2" view="all"><ce:section-title id="sectitle0110">Systemic</ce:section-title><ce:para id="p0230" view="all">Immunosuppression was induced in 14 rabbits with intramuscular injection of DXP (Dexa-ratiopharm, Ratiopharm) over 2 days, three times/day, every 6 hr, 2.5-3 mg/kg, modified from a prior study (<ce:cross-ref refid="bib20" id="crosref0495">Jeklova et al., 2008</ce:cross-ref>). On the day of surgery, the animals were injected twice, 12 hr apart, with 2.5-3 mg/kg DXP, followed by a once daily maintenance dose of 2.5-3 mg/kg DXP in the morning until sacrifice. Animals were weighed regularly postimplantation and inspected by a veterinarian when necessary.</ce:para></ce:section></ce:section><ce:section id="sec4.7" view="all"><ce:section-title id="sectitle0115">In Vivo Follow-Up</ce:section-title><ce:para id="p0235" view="all">Rabbits had repetitive noninvasive retinal imaging performed at post-OP days 4, 7, 14, and 28. Anesthesia and pupil dilation were performed as described above. The cornea was frequently lubricated with artificial tears (Optive, Allergan) to maintain its optical clarity throughout imaging.</ce:para><ce:section id="sec4.7.1" view="all"><ce:section-title id="sectitle0120">Spectral Domain Optical Coherence Tomography and Confocal Scanning Laser Ophthalmoscopy</ce:section-title><ce:para id="p0240" view="all">The Spectralis HRA/OCT device (Heidelberg Engineering) was used to acquire laser-interferometric reflectance OCT images of the retina and choroid, with resolutions comparable to a light microscopic section. Longitudinal and transversal line OCT scans through the center of the implant were taken with the 30-degrees-of-visual-field setting of the Spectralis. Volume scans were obtained with 60 μm distance between each scan with the device set to 20 × 20 degrees of visual field centered on the implant. To approximate human optical parameters to rabbit eyes, the Spectralis' corneal curvature settings were set by default to 4.2 mm. Red-free and infrared cSLO images were taken at 30 degrees of visual field in the HRA mode of the device.</ce:para></ce:section><ce:section id="sec4.7.2" view="all"><ce:section-title id="sectitle0125">Color Fundus Photographs</ce:section-title><ce:para id="p0245" view="all">A Zeiss FF 450IR camera set to 30 degrees of visual field was used to obtain color photographs to document funduscopic changes around the implant site.</ce:para></ce:section></ce:section><ce:section id="sec4.8" view="all"><ce:section-title id="sectitle0130">Histology</ce:section-title><ce:section id="sec4.8.1" view="all"><ce:section-title id="sectitle0135">Perfusion Fixation and Sectioning</ce:section-title><ce:para id="p0250" view="all">Rabbits were sacrificed 4 weeks after implantation in deep intramuscular anesthesia with an intracardial injection of T61. The animals were desanguinated and then perfusion-fixed with 2% glutaraldehyde (GA) or 4% formaldehyde (FA) both diluted in 0.1 M phosphate buffer. The enucleated eyes were then immersion-fixed overnight in the same fixative. Anterior segments were cut away with Vannas scissors and the eyecups photographed under a binocular microscope (Zeiss OPMI 1) with a 5-megapixel smartphone digital camera (iPhone 4, Apple). Full-thickness samples (retina-sclera) of the implantation site were cut with a surgical blade (Feather No. 22). GA probes were embedded in Spurr's resin (Sigma, EM0300-1KT) and 1 to 2 μm semithin sections cut and then stained with toluidine blue. FA-fixed materials in paraffin were cut into 5 μm sections and stained with hematoxylin/eosin or Mayer's hematoxylin alone (if combined with immunohistochemistry, see below). Light micrographs were taken on an Olympus BX50 microscope equipped with a Nikon DS-Vi1 digital camera.</ce:para></ce:section><ce:section id="sec4.8.2" view="all"><ce:section-title id="sectitle0140">Transmission Electron Microscopy</ce:section-title><ce:para id="p0255" view="all">Ultrathin sections from both implant types (Spurr-embedded, see above) were analyzed using a Philips CM 10 electron microscope (Philips). Images were taken with Megaview3 CCD digital camera and coupled with digital image software analysis (Olympus).</ce:para></ce:section><ce:section id="sec4.8.3" view="all"><ce:section-title id="sectitle0145">Immunolabeling</ce:section-title><ce:section id="sec4.8.3.1" view="all"><ce:section-title id="sectitle0150">Transwell Membranes</ce:section-title><ce:para id="p0260" view="all">Transwell membranes were processed for immunocytochemistry against Claudin-19 (1:100; R&amp;D Systems), ZO-1 (1:100; Invitrogen), Ezrin (1:100; Cell Signaling Technology), MCT-1 (1:100; Sigma), CRALBP (1:100; Abcam), RPE65 (1:100; a gift from Dr. T. Michael Redmond, National Institutes of Health [NIH]), and nuclear stain DAPI (1:10,000; Invitrogen). Secondary antibodies used at 1:1,000 dilutions were Alexa Fluor 488-goat anti-mouse IgG2A, Alexa Fluor 546-goat anti-rabbit immunoglobulin G (IgG) (H<ce:sup loc="post">+</ce:sup>L), Alexa Fluor 488-goat anti-mouse IgG1, and Alexa Fluor 546-goat anti-mouse IgG (H<ce:sup loc="post">+</ce:sup>L) (Invitrogen). Transwell membranes were fixed with ice-cold 4% FA solution for 15 min and then blocked and permeabilized with a solution containing 0.1% saponin, 5% normal goat serum, and 1% bovine serum albumin in phosphate-buffered saline. Controls included incubations of secondary antibodies in the absence of primary antibodies and block solutions in the absence of primary/secondary antibodies. Fluorescent images were collected using a Leica TCS SP5 confocal microscope.</ce:para></ce:section><ce:section id="sec4.8.3.2" view="all"><ce:section-title id="sectitle0155">Paraffin Sections</ce:section-title><ce:para id="p0265" view="all">Some paraffin sections obtained from implant regions were processed for immunocytochemistry against pan-cytokeratin (1:100; catalog number ab11213, Abcam), ezrin (1:50; CST), MCT-1 (1:50; LifeSpan Biosciences), Ki67 (1:50; Sigma), phosphohistone H3 (1:50; Millipore), caspase-3 (1:50, Promega), and human-specific antibody SC121 (1:50; Stem Cells) to verify the presence of human RPE cells on the subretinally implanted cell carriers. Pan-cytokeratin was visualized with the Biotin-ExtrAvidin-AEC chromogen system. All other primary antibodies were visualized using Alexa Fluor secondary antibodies as mentioned above.</ce:para></ce:section></ce:section></ce:section></ce:section></ce:sections><ce:acknowledgment id="ack0010" view="all"><ce:section-title id="sectitle0160">Acknowledgments</ce:section-title><ce:para id="p0270" view="all">This work was supported by BONFOR/Gerok Scholarships O-137.0015 (to B.V.S.), Ruediger Foundation grants (to B.V.S.), State Scholarship Fund/Chinese Scholarship Council 2008627116 (to Z.L.), NIH - National Eye Institute 5R01EY022079-02 (to S.T.), and NYSDOH contract C028504 (to S.T. and J.H.S.) supported by the Empire State Stem Cell Fund. Opinions expressed here are solely those of the authors and do not necessarily reflect those of the National Institutes of Health, Empire State Stem Cell Board, the New York State Department of Health, or the state of New York. A European patent application on the shooter instrument was submitted by B.V.S., Z.L., R.B., N.E. and F.G.H. (PCT/EP2012/058083). S.T. and J.H.S. have a granted US patent on aRPESC (application number 12/428,456). This paper was presented in part at the 20<ce:sup loc="post">th</ce:sup> ISER meeting in July 2012 and the 3<ce:sup loc="post">rd</ce:sup> TERMIS World congress in September 2012. C. Strack assisted with histologic processing, and J. Bedorf at the Institute of Pathology, University of Bonn was very helpful in obtaining transmission electron micrographs. Dr. Andrea Lohmer of HET facility, University Clinics Bonn, Bonn, Germany is gratefully acknowledged for her veterinarian services. N. Braun of Geuder AG Heidelberg, Germany provided support for instrumentation used in rabbits. We thank Carol Charniga for invaluable help with RPE dissections and culture maintenance.</ce:para></ce:acknowledgment><ce:appendices view="all"><ce:section id="app1" view="compact-standard"><ce:section-title id="sectitle0165">Supplemental Information</ce:section-title><ce:para id="p0275" view="all">Supplemental Information includes Supplemental Experimental Procedures, three figures, one table, and five movies and can be found with this article online at <ce:inter-ref xlink:href="doi:10.1016/j.stemcr.2013.11.005" id="intref0015" xlink:type="simple">http://dx.doi.org/10.1016/j.stemcr.2013.11.005</ce:inter-ref>.</ce:para></ce:section><ce:section id="app2" view="extended"><ce:section-title id="sectitle0170">Supplemental Information</ce:section-title><ce:para id="p0280" view="all"><ce:display><ce:e-component id="mmc1"><ce:label>Document S1. Supplemental Experimental Procedures, Figures S1-S3, and Table S1</ce:label><ce:link locator="mmc1"/></ce:e-component></ce:display><ce:display><ce:e-component id="mmc2"><ce:label>Movie S1. Full Implantation Movie with Fetal hRPE/PET Implant</ce:label><ce:caption id="cap0010"><ce:simple-para id="espara0010" view="all">(1) An enlarged opening in the retina (retinotomy) is created with vertical scissors. (2) The implant is inserted with a custom-made instrument from epiretinal underneath the retina. (3) The implant is pushed further into the subretinal space with half-closed branches of 23G scissors. (4) Final positioning of the graft is achieved with a 41G Teflon-cannula.</ce:simple-para></ce:caption><ce:link locator="mmc2"/></ce:e-component></ce:display><ce:display><ce:e-component id="mmc3"><ce:label>Movie S2. SD-OCT Volume Scan and Three-Dimensional Topographic Retinal Surface View of PET-Only Implant from Figure S1</ce:label><ce:link locator="mmc3"/></ce:e-component></ce:display><ce:display><ce:e-component id="mmc4"><ce:label>Movie S3. SD-OCT Volume Scan and Three-Dimensional Topographic Retinal Surface View of Representative Fetal hRPE Implant from Figure 2</ce:label><ce:link locator="mmc4"/></ce:e-component></ce:display><ce:display><ce:e-component id="mmc5"><ce:label>Movie S4. SD-OCT Volume Scan and Three-Dimensional Topographic Retinal Surface View of Representative Adult hRPE Implant from Figure 2</ce:label><ce:link locator="mmc5"/></ce:e-component></ce:display><ce:display><ce:e-component id="mmc6"><ce:label>Movie S5. SD-OCT Volume Scan and Three-Dimensional Topographic Retinal Surface View of Representative Fetal hRPE Implant in DXP-Immunosuppressed Rabbit from Figure 4</ce:label><ce:link locator="mmc6"/></ce:e-component></ce:display></ce:para></ce:section></ce:appendices></body><tail view="all"><ce:bibliography id="cebib0010" view="all"><ce:section-title id="sectitle0175">References</ce:section-title><ce:bibliography-sec id="cebibsec0010" view="all"><ce:bib-reference id="bib1"><ce:label>Abe et al., 1999</ce:label><sb:reference id="sref1"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Abe</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Takeda</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Yamada</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Akaishi</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Tomita</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Sato</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Tamai</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Cytokine gene expression after subretinal transplantation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Tohoku J. Exp. Med.</sb:maintitle></sb:title><sb:volume-nr>189</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>179</sb:first-page><sb:last-page>189</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib2"><ce:label>Bhatt et al., 1994</ce:label><sb:reference id="sref2"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>N.S.</ce:given-name><ce:surname>Bhatt</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Newsome</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Fenech</ce:surname></sb:author><sb:author><ce:given-name>T.P.</ce:given-name><ce:surname>Hessburg</ce:surname></sb:author><sb:author><ce:given-name>J.G.</ce:given-name><ce:surname>Diamond</ce:surname></sb:author><sb:author><ce:given-name>M.V.</ce:given-name><ce:surname>Miceli</ce:surname></sb:author><sb:author><ce:given-name>K.E.</ce:given-name><ce:surname>Kratz</ce:surname></sb:author><sb:author><ce:given-name>P.D.</ce:given-name><ce:surname>Oliver</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Experimental transplantation of human retinal pigment epithelial cells on collagen substrates</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am. J. Ophthalmol.</sb:maintitle></sb:title><sb:volume-nr>117</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>214</sb:first-page><sb:last-page>221</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib3"><ce:label>Binder et al., 2007</ce:label><sb:reference id="sref3"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Binder</ce:surname></sb:author><sb:author><ce:given-name>B.V.</ce:given-name><ce:surname>Stanzel</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Krebs</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Glittenberg</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Transplantation of the RPE in AMD</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Prog. Retin. Eye Res.</sb:maintitle></sb:title><sb:volume-nr>26</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>516</sb:first-page><sb:last-page>554</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib4"><ce:label>Blenkinsop et al., 2013</ce:label><sb:reference id="sref4"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>T.A.</ce:given-name><ce:surname>Blenkinsop</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Salero</ce:surname></sb:author><sb:author><ce:given-name>J.H.</ce:given-name><ce:surname>Stern</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Temple</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The culture and maintenance of functional retinal pigment epithelial monolayers from adult human eye</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Methods Mol. Biol.</sb:maintitle></sb:title><sb:volume-nr>945</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>45</sb:first-page><sb:last-page>65</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib5"><ce:label>Bonilha et al., 1999</ce:label><sb:reference id="sref5"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>V.L.</ce:given-name><ce:surname>Bonilha</ce:surname></sb:author><sb:author><ce:given-name>S.C.</ce:given-name><ce:surname>Finnemann</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Rodriguez-Boulan</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Ezrin promotes morphogenesis of apical microvilli and basal infoldings in retinal pigment epithelium</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>147</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>1533</sb:first-page><sb:last-page>1548</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib6"><ce:label>Bunt-Milam and Saari, 1983</ce:label><sb:reference id="sref6"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.H.</ce:given-name><ce:surname>Bunt-Milam</ce:surname></sb:author><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Saari</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Immunocytochemical localization of two retinoid-binding proteins in vertebrate retina</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>97</sb:volume-nr></sb:series><sb:date>1983</sb:date></sb:issue><sb:pages><sb:first-page>703</sb:first-page><sb:last-page>712</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib7"><ce:label>Burke, 2008</ce:label><sb:reference id="sref7"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Burke</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Epithelial phenotype and the RPE: is the answer blowing in the Wnt?</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Prog. Retin. Eye Res.</sb:maintitle></sb:title><sb:volume-nr>27</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>579</sb:first-page><sb:last-page>595</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib8"><ce:label>Carr et al., 2009</ce:label><sb:reference id="sref8"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.J.</ce:given-name><ce:surname>Carr</ce:surname></sb:author><sb:author><ce:given-name>A.A.</ce:given-name><ce:surname>Vugler</ce:surname></sb:author><sb:author><ce:given-name>S.T.</ce:given-name><ce:surname>Hikita</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Lawrence</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Gias</ce:surname></sb:author><sb:author><ce:given-name>L.L.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Buchholz</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Ahmado</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Semo</ce:surname></sb:author><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Smart</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>PLoS ONE</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>e8152</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib9"><ce:label>da Cruz et al., 2007</ce:label><sb:reference id="sref9"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>da Cruz</ce:surname></sb:author><sb:author><ce:given-name>F.K.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Ahmado</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Greenwood</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Coffey</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>RPE transplantation and its role in retinal disease</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Prog. Retin. Eye Res.</sb:maintitle></sb:title><sb:volume-nr>26</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>598</sb:first-page><sb:last-page>635</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib10"><ce:label>Del Priore et al., 2001</ce:label><sb:reference id="sref10"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>L.V.</ce:given-name><ce:surname>Del Priore</ce:surname></sb:author><sb:author><ce:given-name>H.J.</ce:given-name><ce:surname>Kaplan</ce:surname></sb:author><sb:author><ce:given-name>T.H.</ce:given-name><ce:surname>Tezel</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Hayashi</ce:surname></sb:author><sb:author><ce:given-name>A.S.</ce:given-name><ce:surname>Berger</ce:surname></sb:author><sb:author><ce:given-name>W.R.</ce:given-name><ce:surname>Green</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Retinal pigment epithelial cell transplantation after subfoveal membranectomy in age-related macular degeneration: clinicopathologic correlation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am. J. Ophthalmol.</sb:maintitle></sb:title><sb:volume-nr>131</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>472</sb:first-page><sb:last-page>480</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib11"><ce:label>Diniz et al., 2013</ce:label><sb:reference id="sref11"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Diniz</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Thomas</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Thomas</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Ribeiro</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Hu</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Brant</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Ahuja</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Zhu</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Liu</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Koss</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Invest. Ophthalmol. Vis. Sci.</sb:maintitle></sb:title><sb:volume-nr>54</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>5087</sb:first-page><sb:last-page>5096</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib12"><ce:label>Enzmann et al., 2000</ce:label><sb:reference id="sref12"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Enzmann</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Faude</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Wiedemann</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Kohen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The local and systemic secretion of the pro-inflammatory cytokine interleukin-6 after transplantation of retinal pigment epithelium cells in a rabbit model</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr. Eye Res.</sb:maintitle></sb:title><sb:volume-nr>21</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>530</sb:first-page><sb:last-page>534</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib13"><ce:label>Gabrielian et al., 1999</ce:label><sb:reference id="sref13"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Gabrielian</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Oganesian</ce:surname></sb:author><sb:author><ce:given-name>S.C.</ce:given-name><ce:surname>Patel</ce:surname></sb:author><sb:author><ce:given-name>M.S.</ce:given-name><ce:surname>Verp</ce:surname></sb:author><sb:author><ce:given-name>J.T.</ce:given-name><ce:surname>Ernest</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Cellular response in rabbit eyes after human fetal RPE cell transplantation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Graefes Arch. Clin. Exp. Ophthalmol.</sb:maintitle></sb:title><sb:volume-nr>237</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>326</sb:first-page><sb:last-page>335</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib14"><ce:label>He et al., 1994</ce:label><sb:reference id="sref14"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>He</ce:surname></sb:author><sb:author><ce:given-name>H.M.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Ye</ce:surname></sb:author><sb:author><ce:given-name>T.E.</ce:given-name><ce:surname>Ogden</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Ryan</ce:surname></sb:author><sb:author><ce:given-name>D.R.</ce:given-name><ce:surname>Hinton</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Dexamethasone induced proliferation of cultured retinal pigment epithelial cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr. Eye Res.</sb:maintitle></sb:title><sb:volume-nr>13</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>257</sb:first-page><sb:last-page>261</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib15"><ce:label>Hirami et al., 2009</ce:label><sb:reference id="sref15"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Hirami</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Osakada</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Takahashi</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Okita</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Yamanaka</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Ikeda</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Yoshimura</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Takahashi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Generation of retinal cells from mouse and human induced pluripotent stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Neurosci. Lett.</sb:maintitle></sb:title><sb:volume-nr>458</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>126</sb:first-page><sb:last-page>131</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib16"><ce:label>Hu and Bok, 2001</ce:label><sb:reference id="sref16"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Hu</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Bok</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Vis.</sb:maintitle></sb:title><sb:volume-nr>7</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>14</sb:first-page><sb:last-page>19</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib17"><ce:label>Huang et al., 1998</ce:label><sb:reference id="sref17"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Huang</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Ishida</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Hersh</ce:surname></sb:author><sb:author><ce:given-name>I.K.</ce:given-name><ce:surname>Sugino</ce:surname></sb:author><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Zarbin</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Preparation and transplantation of photoreceptor sheets</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr. Eye Res.</sb:maintitle></sb:title><sb:volume-nr>17</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>573</sb:first-page><sb:last-page>585</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib18"><ce:label>Hynes and Lavik, 2010</ce:label><sb:reference id="sref18"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.R.</ce:given-name><ce:surname>Hynes</ce:surname></sb:author><sb:author><ce:given-name>E.B.</ce:given-name><ce:surname>Lavik</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Graefes Arch. Clin. Exp. Ophthalmol.</sb:maintitle></sb:title><sb:volume-nr>248</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>763</sb:first-page><sb:last-page>778</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib19"><ce:label>Ivert et al., 2002</ce:label><sb:reference id="sref19"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Ivert</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Kjeldbye</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Gouras</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Long-term effects of short-term retinal bleb detachments in rabbits</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Graefes Arch. Clin. Exp. Ophthalmol.</sb:maintitle></sb:title><sb:volume-nr>240</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>232</sb:first-page><sb:last-page>237</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib20"><ce:label>Jeklova et al., 2008</ce:label><sb:reference id="sref20"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Jeklova</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Leva</ce:surname></sb:author><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Jaglic</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Faldyna</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Dexamethasone-induced immunosuppression: a rabbit model</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Vet. Immunol. Immunopathol.</sb:maintitle></sb:title><sb:volume-nr>122</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>231</sb:first-page><sb:last-page>240</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib21"><ce:label>Jiang et al., 1994</ce:label><sb:reference id="sref21"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>L.Q.</ce:given-name><ce:surname>Jiang</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Jorquera</ce:surname></sb:author><sb:author><ce:given-name>J.W.</ce:given-name><ce:surname>Streilein</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Immunologic consequences of intraocular implantation of retinal pigment epithelial allografts</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Exp. Eye Res.</sb:maintitle></sb:title><sb:volume-nr>58</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>719</sb:first-page><sb:last-page>728</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib22"><ce:label>Kearns et al., 2012</ce:label><sb:reference id="sref22"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Kearns</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Mistry</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Mason</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Krishna</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Sheridan</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Short</ce:surname></sb:author><sb:author><ce:given-name>R.L.</ce:given-name><ce:surname>Williams</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Plasma polymer coatings to aid retinal pigment epithelial growth for transplantation in the treatment of age related macular degeneration</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Mater. Sci. Mater. Med.</sb:maintitle></sb:title><sb:volume-nr>23</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>2013</sb:first-page><sb:last-page>2021</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib23"><ce:label>Klimanskaya et al., 2004</ce:label><sb:reference id="sref23"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Klimanskaya</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Hipp</ce:surname></sb:author><sb:author><ce:given-name>K.A.</ce:given-name><ce:surname>Rezai</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>West</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Atala</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Lanza</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cloning Stem Cells</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>217</sb:first-page><sb:last-page>245</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib24"><ce:label>Lai, 2009</ce:label><sb:reference id="sref24"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.Y.</ce:given-name><ce:surname>Lai</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The role of bloom index of gelatin on the interaction with retinal pigment epithelial cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Int. J. Mol. Sci.</sb:maintitle></sb:title><sb:volume-nr>10</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>3442</sb:first-page><sb:last-page>3456</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib25"><ce:label>Lai et al., 2000</ce:label><sb:reference id="sref25"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>C.C.</ce:given-name><ce:surname>Lai</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Gouras</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Doi</ce:surname></sb:author><sb:author><ce:given-name>S.H.</ce:given-name><ce:surname>Tsang</ce:surname></sb:author><sb:author><ce:given-name>S.P.</ce:given-name><ce:surname>Goff</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Ashton</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Local immunosuppression prolongs survival of RPE xenografts labeled by retroviral gene transfer</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Invest. Ophthalmol. Vis. Sci.</sb:maintitle></sb:title><sb:volume-nr>41</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>3134</sb:first-page><sb:last-page>3141</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib26"><ce:label>Liao et al., 2010</ce:label><sb:reference id="sref26"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.L.</ce:given-name><ce:surname>Liao</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Yu</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Huang</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Hu</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Diemer</ce:surname></sb:author><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Ma</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Dvash</ce:surname></sb:author><sb:author><ce:given-name>X.J.</ce:given-name><ce:surname>Yang</ce:surname></sb:author><sb:author><ce:given-name>G.H.</ce:given-name><ce:surname>Travis</ce:surname></sb:author><sb:author><ce:given-name>D.S.</ce:given-name><ce:surname>Williams</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Hum. Mol. Genet.</sb:maintitle></sb:title><sb:volume-nr>19</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>4229</sb:first-page><sb:last-page>4238</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib27"><ce:label>Lim et al., 2012</ce:label><sb:reference id="sref27"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>L.S.</ce:given-name><ce:surname>Lim</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Mitchell</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Seddon</ce:surname></sb:author><sb:author><ce:given-name>F.G.</ce:given-name><ce:surname>Holz</ce:surname></sb:author><sb:author><ce:given-name>T.Y.</ce:given-name><ce:surname>Wong</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Age-related macular degeneration</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Lancet</sb:maintitle></sb:title><sb:volume-nr>379</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>1728</sb:first-page><sb:last-page>1738</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib28"><ce:label>Liu et al., 2013</ce:label><sb:reference id="sref28"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Liu</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Yu</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Holz</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Yang</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Stanzel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Engineering a biocompatible cell carrier with nanofeatured topography for retinal pigment epithelium transplantation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Invest. Ophthalmol. Vis. Sci.</sb:maintitle></sb:title><sb:volume-nr>54</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>1386</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib29"><ce:label>Lu et al., 2012</ce:label><sb:reference id="sref29"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Lu</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Zhu</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Hinton</ce:surname></sb:author><sb:author><ce:given-name>M.S.</ce:given-name><ce:surname>Humayun</ce:surname></sb:author><sb:author><ce:given-name>Y.C.</ce:given-name><ce:surname>Tai</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Mesh-supported submicron parylene-C membranes for culturing retinal pigment epithelial cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biomed. Microdevices</sb:maintitle></sb:title><sb:volume-nr>14</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>659</sb:first-page><sb:last-page>667</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib30"><ce:label>Montezuma et al., 2006</ce:label><sb:reference id="sref30"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.R.</ce:given-name><ce:surname>Montezuma</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Loewenstein</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Scholz</ce:surname></sb:author><sb:author><ce:given-name>J.F.</ce:given-name><ce:surname>Rizzo</ce:surname><ce:suffix>3rd</ce:suffix></sb:author></sb:authors><sb:title><sb:maintitle>Biocompatibility of materials implanted into the subretinal space of Yucatan pigs</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Invest. Ophthalmol. Vis. Sci.</sb:maintitle></sb:title><sb:volume-nr>47</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>3514</sb:first-page><sb:last-page>3522</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib31"><ce:label>Nicolini et al., 2000</ce:label><sb:reference id="sref31"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Nicolini</ce:surname></sb:author><sb:author><ce:given-name>J.F.</ce:given-name><ce:surname>Kiilgaard</ce:surname></sb:author><sb:author><ce:given-name>A.K.</ce:given-name><ce:surname>Wiencke</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Heegaard</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Scherfig</ce:surname></sb:author><sb:author><ce:given-name>J.U.</ce:given-name><ce:surname>Prause</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>la Cour</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The anterior lens capsule used as support material in RPE cell-transplantation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Acta Ophthalmol. Scand.</sb:maintitle></sb:title><sb:volume-nr>78</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>527</sb:first-page><sb:last-page>531</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib32"><ce:label>Peng et al., 2011</ce:label><sb:reference id="sref32"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Peng</ce:surname></sb:author><sb:author><ce:given-name>V.S.</ce:given-name><ce:surname>Rao</ce:surname></sb:author><sb:author><ce:given-name>R.A.</ce:given-name><ce:surname>Adelman</ce:surname></sb:author><sb:author><ce:given-name>L.J.</ce:given-name><ce:surname>Rizzolo</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Claudin-19 and the barrier properties of the human retinal pigment epithelium</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Invest. Ophthalmol. Vis. Sci.</sb:maintitle></sb:title><sb:volume-nr>52</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>1392</sb:first-page><sb:last-page>1403</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib33"><ce:label>Philp et al., 1998</ce:label><sb:reference id="sref33"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>N.J.</ce:given-name><ce:surname>Philp</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Yoon</ce:surname></sb:author><sb:author><ce:given-name>E.F.</ce:given-name><ce:surname>Grollman</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Monocarboxylate transporter MCT1 is located in the apical membrane and MCT3 in the basal membrane of rat RPE</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am. J. Physiol.</sb:maintitle></sb:title><sb:volume-nr>274</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>R1824</sb:first-page><sb:last-page>R1828</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib34"><ce:label>Redmond et al., 1998</ce:label><sb:reference id="sref34"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>T.M.</ce:given-name><ce:surname>Redmond</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Yu</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Lee</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Bok</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Hamasaki</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Goletz</ce:surname></sb:author><sb:author><ce:given-name>J.X.</ce:given-name><ce:surname>Ma</ce:surname></sb:author><sb:author><ce:given-name>R.K.</ce:given-name><ce:surname>Crouch</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Pfeifer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Genet.</sb:maintitle></sb:title><sb:volume-nr>20</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>344</sb:first-page><sb:last-page>351</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib35"><ce:label>Rezai et al., 2000</ce:label><sb:reference id="sref35"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.A.</ce:given-name><ce:surname>Rezai</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Farrokh-Siar</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Godowski</ce:surname></sb:author><sb:author><ce:given-name>S.C.</ce:given-name><ce:surname>Patel</ce:surname></sb:author><sb:author><ce:given-name>J.T.</ce:given-name><ce:surname>Ernest</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A model for xenogenic immune response</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Graefes Arch. Clin. Exp. Ophthalmol.</sb:maintitle></sb:title><sb:volume-nr>238</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>352</sb:first-page><sb:last-page>358</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib36"><ce:label>Salero et al., 2012</ce:label><sb:reference id="sref36"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Salero</ce:surname></sb:author><sb:author><ce:given-name>T.A.</ce:given-name><ce:surname>Blenkinsop</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Corneo</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Harris</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Rabin</ce:surname></sb:author><sb:author><ce:given-name>J.H.</ce:given-name><ce:surname>Stern</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Temple</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Adult human RPE can be activated into a multipotent stem cell that produces mesenchymal derivatives</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>10</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>88</sb:first-page><sb:last-page>95</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib37"><ce:label>Schwartz et al., 2012</ce:label><sb:reference id="sref37"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.D.</ce:given-name><ce:surname>Schwartz</ce:surname></sb:author><sb:author><ce:given-name>J.P.</ce:given-name><ce:surname>Hubschman</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Heilwell</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Franco-Cardenas</ce:surname></sb:author><sb:author><ce:given-name>C.K.</ce:given-name><ce:surname>Pan</ce:surname></sb:author><sb:author><ce:given-name>R.M.</ce:given-name><ce:surname>Ostrick</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Mickunas</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Gay</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Klimanskaya</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Lanza</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Embryonic stem cell trials for macular degeneration: a preliminary report</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Lancet</sb:maintitle></sb:title><sb:volume-nr>379</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>713</sb:first-page><sb:last-page>720</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib38"><ce:label>Sheng et al., 1995</ce:label><sb:reference id="sref38"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Sheng</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Gouras</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Cao</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Berglin</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Kjeldbye</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Lopez</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Rosskothen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Patch transplants of human fetal retinal pigment epithelium in rabbit and monkey retina</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Invest. Ophthalmol. Vis. Sci.</sb:maintitle></sb:title><sb:volume-nr>36</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>381</sb:first-page><sb:last-page>390</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib39"><ce:label>Singer et al., 2012</ce:label><sb:reference id="sref39"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Singer</ce:surname></sb:author><sb:author><ce:given-name>C.C.</ce:given-name><ce:surname>Awh</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Sadda</ce:surname></sb:author><sb:author><ce:given-name>W.R.</ce:given-name><ce:surname>Freeman</ce:surname></sb:author><sb:author><ce:given-name>A.N.</ce:given-name><ce:surname>Antoszyk</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Wong</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Tuomi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Ophthalmology</sb:maintitle></sb:title><sb:volume-nr>119</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>1175</sb:first-page><sb:last-page>1183</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib40"><ce:label>Singh et al., 2013</ce:label><sb:reference id="sref40"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Singh</ce:surname></sb:author><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Phillips</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Kuai</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Meyer</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Martin</ce:surname></sb:author><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Smith</ce:surname></sb:author><sb:author><ce:given-name>E.T.</ce:given-name><ce:surname>Perez</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Shen</ce:surname></sb:author><sb:author><ce:given-name>K.A.</ce:given-name><ce:surname>Wallace</ce:surname></sb:author><sb:author><ce:given-name>E.E.</ce:given-name><ce:surname>Capowski</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Functional analysis of serially expanded human iPS cell-derived RPE cultures</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Invest. Ophthalmol. Vis. Sci.</sb:maintitle></sb:title><sb:volume-nr>54</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>6767</sb:first-page><sb:last-page>6778</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib41"><ce:label>Stanzel and Holz, 2012</ce:label><sb:reference id="sref41"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>B.V.</ce:given-name><ce:surname>Stanzel</ce:surname></sb:author><sb:author><ce:given-name>F.G.</ce:given-name><ce:surname>Holz</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Surgical strategies for AMD</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:editors><sb:editor><ce:given-name>G.L.</ce:given-name><ce:surname>Spaeth</ce:surname></sb:editor><sb:editor><ce:given-name>A.</ce:given-name><ce:surname>Kampik</ce:surname></sb:editor></sb:editors><sb:title><sb:maintitle>Ophthalmic Surgery: Principles and Practice</sb:maintitle></sb:title><sb:date>2012</sb:date><sb:publisher><sb:name>Elsevier</sb:name><sb:location>Philadelphia</sb:location></sb:publisher></sb:edited-book></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib42"><ce:label>Stanzel et al., 2012</ce:label><sb:reference id="sref42"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>B.V.</ce:given-name><ce:surname>Stanzel</ce:surname></sb:author><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Liu</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Brinken</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Braun</ce:surname></sb:author><sb:author><ce:given-name>F.G.</ce:given-name><ce:surname>Holz</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Eter</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Subretinal delivery of ultrathin rigid-elastic cell carriers using a metallic shooter instrument and biodegradable hydrogel encapsulation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Invest. Ophthalmol. Vis. Sci.</sb:maintitle></sb:title><sb:volume-nr>53</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>490</sb:first-page><sb:last-page>500</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib43"><ce:label>Strauss, 2005</ce:label><sb:reference id="sref43"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>O.</ce:given-name><ce:surname>Strauss</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The retinal pigment epithelium in visual function</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Physiol. Rev.</sb:maintitle></sb:title><sb:volume-nr>85</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>845</sb:first-page><sb:last-page>881</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib44"><ce:label>Subrizi et al., 2012</ce:label><sb:reference id="sref44"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Subrizi</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Hiidenmaa</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Ilmarinen</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Nymark</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Dubruel</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Uusitalo</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Yliperttula</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Urtti</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Skottman</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Generation of hESC-derived retinal pigment epithelium on biopolymer coated polyimide membranes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biomaterials</sb:maintitle></sb:title><sb:volume-nr>33</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>8047</sb:first-page><sb:last-page>8054</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib45"><ce:label>Sugino et al., 2011</ce:label><sb:reference id="sref45"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>I.K.</ce:given-name><ce:surname>Sugino</ce:surname></sb:author><sb:author><ce:given-name>Q.</ce:given-name><ce:surname>Sun</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>C.F.</ce:given-name><ce:surname>Nunes</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Cheewatrakoolpong</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Rapista</ce:surname></sb:author><sb:author><ce:given-name>A.C.</ce:given-name><ce:surname>Johnson</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Malcuit</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Klimanskaya</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Lanza</ce:surname></sb:author><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Zarbin</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Comparison of FRPE and human embryonic stem cell-derived RPE behavior on aged human Bruch's membrane</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Invest. Ophthalmol. Vis. Sci.</sb:maintitle></sb:title><sb:volume-nr>52</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>4979</sb:first-page><sb:last-page>4997</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib46"><ce:label>Sugita, 2009</ce:label><sb:reference id="sref46"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Sugita</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Role of ocular pigment epithelial cells in immune privilege</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch. Immunol. Ther. Exp. (Warsz.)</sb:maintitle></sb:title><sb:volume-nr>57</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>263</sb:first-page><sb:last-page>268</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib47"><ce:label>Szurman et al., 2006</ce:label><sb:reference id="sref47"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Szurman</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Roters</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Grisanti</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Aisenbrey</ce:surname></sb:author><sb:author><ce:given-name>U.</ce:given-name><ce:surname>Schraermeyer</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Lüke</ce:surname></sb:author><sb:author><ce:given-name>K.U.</ce:given-name><ce:surname>Bartz-Schmidt</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Thumann</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Ultrastructural changes after artificial retinal detachment with modified retinal adhesion</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Invest. Ophthalmol. Vis. Sci.</sb:maintitle></sb:title><sb:volume-nr>47</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>4983</sb:first-page><sb:last-page>4989</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib48"><ce:label>van Zeeburg et al., 2012</ce:label><sb:reference id="sref48"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>E.J.</ce:given-name><ce:surname>van Zeeburg</ce:surname></sb:author><sb:author><ce:given-name>K.J.</ce:given-name><ce:surname>Maaijwee</ce:surname></sb:author><sb:author><ce:given-name>T.O.</ce:given-name><ce:surname>Missotten</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Heimann</ce:surname></sb:author><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>van Meurs</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: results up to 7 years</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Ophthalmol</sb:maintitle></sb:title><sb:volume-nr>153</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>120</sb:first-page><sb:last-page>127</sb:last-page></sb:pages></sb:host><sb:comment>e122</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib49"><ce:label>Verstraeten et al., 1993</ce:label><sb:reference id="sref49"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>T.C.</ce:given-name><ce:surname>Verstraeten</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Chapman</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Hartzer</ce:surname></sb:author><sb:author><ce:given-name>B.S.</ce:given-name><ce:surname>Winkler</ce:surname></sb:author><sb:author><ce:given-name>M.T.</ce:given-name><ce:surname>Trese</ce:surname></sb:author><sb:author><ce:given-name>G.A.</ce:given-name><ce:surname>Williams</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Pharmacologic induction of posterior vitreous detachment in the rabbit</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch. Ophthalmol.</sb:maintitle></sb:title><sb:volume-nr>111</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>849</sb:first-page><sb:last-page>854</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib50"><ce:label>Wang et al., 2002</ce:label><sb:reference id="sref50"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Xu</ce:surname></sb:author><sb:author><ce:given-name>J.H.</ce:given-name><ce:surname>Wu</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Xia</ce:surname></sb:author><sb:author><ce:given-name>H.L.</ce:given-name><ce:surname>Sun</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Xu</ce:surname></sb:author><sb:author><ce:given-name>Q.</ce:given-name><ce:surname>Huang</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>[Long-term outcome of gfp gene modified human RPE xenografts into the subretinal space of rabbits]</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)</sb:maintitle></sb:title><sb:volume-nr>34</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>643</sb:first-page><sb:last-page>649</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib51"><ce:label>Wenkel and Streilein, 1998</ce:label><sb:reference id="sref51"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Wenkel</ce:surname></sb:author><sb:author><ce:given-name>J.W.</ce:given-name><ce:surname>Streilein</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Analysis of immune deviation elicited by antigens injected into the subretinal space</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Invest. Ophthalmol. Vis. Sci.</sb:maintitle></sb:title><sb:volume-nr>39</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>1823</sb:first-page><sb:last-page>1834</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib52"><ce:label>Wenkel and Streilein, 2000</ce:label><sb:reference id="sref52"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Wenkel</ce:surname></sb:author><sb:author><ce:given-name>J.W.</ce:given-name><ce:surname>Streilein</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Evidence that retinal pigment epithelium functions as an immune-privileged tissue</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Invest. Ophthalmol. Vis. Sci.</sb:maintitle></sb:title><sb:volume-nr>41</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>3467</sb:first-page><sb:last-page>3473</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib53"><ce:label>Zhang and Bok, 1998</ce:label><sb:reference id="sref53"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Bok</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Transplantation of retinal pigment epithelial cells and immune response in the subretinal space</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Invest. Ophthalmol. Vis. Sci.</sb:maintitle></sb:title><sb:volume-nr>39</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>1021</sb:first-page><sb:last-page>1027</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article></xocs:serial-item></xocs:doc>
